This is a Validated Antibody Database (VAD) review about human PARP, based on 607 published articles (read how Labome selects the articles), using PARP antibody in all methods. It is aimed to help Labome visitors find the most suited PARP antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PARP synonym: ADPRT; ADPRT 1; ADPRT1; ARTD1; PARP; PARP-1; PPOL; pADPRT-1

Knockout validation
Bio-Rad
mouse monoclonal (A6.4.12)
  • western blot knockout validation; human; loading ...; fig 1a
  • immunohistochemistry; human; loading ...; fig 1b
In order to investigate the roles of PARP2 and PARP3 during DNA break repair, Bio-Rad PARP antibody (Serotec, MCA1522G) was used in western blot knockout validation on human samples (fig 1a) and in immunohistochemistry on human samples (fig 1b). Nucleic Acids Res (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (46D11)
  • immunocytochemistry knockout validation; human; 1:1000; loading ...; fig 2a
  • western blot knockout validation; human; 1:1000; loading ...; fig s3c
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Cell Signaling Technology PARP antibody (CST, 46D11) was used in immunocytochemistry knockout validation on human samples at 1:1000 (fig 2a), in western blot knockout validation on human samples at 1:1000 (fig s3c) and in immunohistochemistry - paraffin section on human samples (fig 4a). Molecules (2020) ncbi
Abcam
domestic rabbit monoclonal (E102)
  • western blot; human; 1:1000; loading ...; fig 3c
Abcam PARP antibody (Abcam, ab32138) was used in western blot on human samples at 1:1000 (fig 3c). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; loading ...; fig 2c
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples (fig 2c). Theranostics (2020) ncbi
domestic rabbit monoclonal (EPR18461)
  • western blot; human; loading ...; fig 2c
Abcam PARP antibody (Abcam, ab191217) was used in western blot on human samples (fig 2c). Theranostics (2020) ncbi
domestic rabbit monoclonal (E51)
  • western blot; rat; 1:1000; loading ...; fig 4a
Abcam PARP antibody (Abcam, ab32064) was used in western blot on rat samples at 1:1000 (fig 4a). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (E51)
  • western blot; mouse; 1:1000; loading ...; fig 5g
Abcam PARP antibody (Abcam, ab32064) was used in western blot on mouse samples at 1:1000 (fig 5g). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (E102)
  • western blot; mouse; 1:1000; loading ...; fig 5g
Abcam PARP antibody (Abcam, ab32138) was used in western blot on mouse samples at 1:1000 (fig 5g). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (E51)
  • immunocytochemistry; human; loading ...; fig 1f
Abcam PARP antibody (Abcam, ab32064) was used in immunocytochemistry on human samples (fig 1f). Sci Rep (2020) ncbi
domestic rabbit monoclonal (Y34)
  • western blot; human; 1:3000; loading ...; fig 2b
Abcam PARP antibody (Abcam, ab32561) was used in western blot on human samples at 1:3000 (fig 2b). Med Sci Monit (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; loading ...; fig 4e
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples (fig 4e). Epigenetics (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 4h
Abcam PARP antibody (Abcam, Ab32064) was used in western blot on human samples at 1:1000 (fig 4h). Nat Commun (2019) ncbi
mouse monoclonal (4B5BD2)
  • western blot; human; 1:1000; loading ...; fig 5g
Abcam PARP antibody (Abcam, ab110315) was used in western blot on human samples at 1:1000 (fig 5g). J Cell Sci (2019) ncbi
domestic rabbit monoclonal
  • western blot; human; loading ...; fig 1a
Abcam PARP antibody (Abcam, ab32071) was used in western blot on human samples (fig 1a). Nucleic Acids Res (2019) ncbi
domestic rabbit monoclonal (Y34)
  • western blot; human; loading ...; fig 4b
Abcam PARP antibody (Abcam, ab32561) was used in western blot on human samples (fig 4b). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 9c
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 9c). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:3000; loading ...; fig 3c
  • western blot; rat; fig 3c
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples at 1:3000 (fig 3c) and in western blot on rat samples (fig 3c). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 4c, 4f
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 4c, 4f). Science (2019) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 3d
Abcam PARP antibody (Abcam, ab4830) was used in western blot on rat samples (fig 3d). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; loading ...; fig 5b
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples (fig 5b). Med Sci Monit (2019) ncbi
domestic rabbit monoclonal (EPR18461)
  • western blot; mouse; loading ...; fig s1a
Abcam PARP antibody (Abcam, ab191217) was used in western blot on mouse samples (fig s1a). Cell Res (2019) ncbi
domestic rabbit monoclonal (E102)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4a, 4c, 4e
Abcam PARP antibody (Abcam, ab32138) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4a, 4c, 4e). Hum Pathol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Abcam PARP antibody (Abcam, ab4830) was used in western blot on human samples at 1:1000 (fig 6b). Cancer Sci (2019) ncbi
domestic rabbit monoclonal
  • chromatin immunoprecipitation; rat; loading ...; fig s1a
  • western blot; rat; loading ...; fig s1e
Abcam PARP antibody (Abcam, ab32071) was used in chromatin immunoprecipitation on rat samples (fig s1a) and in western blot on rat samples (fig s1e). Genes Dev (2018) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:20,000; loading ...; fig 3a
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples at 1:20,000 (fig 3a). EMBO Mol Med (2018) ncbi
domestic rabbit monoclonal
  • western blot; human; loading ...; fig 1c
Abcam PARP antibody (Abcam, ab32071) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2b
In order to ask if the small-molecule inhibitor JQ1 in combination with romidepsin serves as a novel therapeutic option for type II testicular germ cell cancers, Abcam PARP antibody (Abcam, ab4830) was used in western blot on human samples at 1:500 (fig 2b). J Cell Mol Med (2017) ncbi
monoclonal
  • western blot; human; 1:500; loading ...; fig s1b
Abcam PARP antibody (Abcam, ab110915) was used in western blot on human samples at 1:500 (fig s1b). Cell Cycle (2017) ncbi
domestic rabbit monoclonal (E51)
  • western blot; Spodoptera litura; fig 5j
Abcam PARP antibody (Abcam, ab32064) was used in western blot on Spodoptera litura samples (fig 5j). Sci Rep (2016) ncbi
domestic rabbit monoclonal (E102)
  • western blot; human; loading ...; fig 4a
Abcam PARP antibody (Abcam, E-102) was used in western blot on human samples (fig 4a). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; fruit fly ; 1:500
In order to study the function of the MeCP2 C-terminus, Abcam PARP antibody (Abcam, Ab2317) was used in immunocytochemistry on fruit fly samples at 1:500. PLoS ONE (2016) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry; human; loading ...; fig 7d
  • western blot; human; loading ...; fig 5c
Abcam PARP antibody (Abcam, ab32064) was used in immunohistochemistry on human samples (fig 7d) and in western blot on human samples (fig 5c). Onco Targets Ther (2016) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; fig 9
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples (fig 9). Autophagy (2016) ncbi
domestic rabbit monoclonal (E102)
  • western blot; human; fig 9
Abcam PARP antibody (Abcam, ab32138) was used in western blot on human samples (fig 9). Autophagy (2016) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 3b
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 3b). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; fig 3
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples (fig 3). J Cancer (2016) ncbi
monoclonal
  • immunohistochemistry; rat; 1:200; fig 1
  • western blot; rat; 1:1000; fig 6
In order to assess the drive of bystander cone photoreceptor cell death in a P23H rhodopsin model of retinal degeneration by NLRP3 inflammasome activation, Abcam PARP antibody (Abcam, ab110915) was used in immunohistochemistry on rat samples at 1:200 (fig 1) and in western blot on rat samples at 1:1000 (fig 6). Hum Mol Genet (2016) ncbi
domestic rabbit monoclonal
  • western blot; human; fig 3
Abcam PARP antibody (Abcam, ab32071) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; fig 6i
Abcam PARP antibody (Abcam, ab 32064) was used in western blot on human samples (fig 6i). Sci Rep (2015) ncbi
domestic rabbit monoclonal
  • western blot; human; fig 5
Abcam PARP antibody (Abcam, ab32071) was used in western blot on human samples (fig 5). Oncogene (2016) ncbi
domestic rabbit monoclonal (Y34)
  • western blot; mouse; fig 6c
Abcam PARP antibody (abcam, ab32561) was used in western blot on mouse samples (fig 6c). Front Pharmacol (2015) ncbi
domestic rabbit monoclonal (E102)
  • immunohistochemistry - paraffin section; rat; 1:500; fig 6a
In order to examine the effects of hypothyroidism on late lactation, Abcam PARP antibody (Abcam, ab32138) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 6a). Mol Cell Endocrinol (2016) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry; mouse; 1:100; fig 5b
Abcam PARP antibody (Abcam, ab32064) was used in immunohistochemistry on mouse samples at 1:100 (fig 5b). Oncotarget (2015) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 2a
Abcam PARP antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 2a). Mol Cancer (2015) ncbi
domestic rabbit monoclonal
  • western blot; human; 1:1000; fig 1
Abcam PARP antibody (Abcam, ab32071) was used in western blot on human samples at 1:1000 (fig 1). Oncotarget (2015) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human
In order to evaluate the role of leptin/STAT3 and HER2 receptor in tamoxifen resistance, Abcam PARP antibody (Abcam, AB32064) was used in western blot on human samples . Cell Oncol (Dordr) (2015) ncbi
domestic rabbit monoclonal (E102)
  • immunohistochemistry - frozen section; rat; 1:50
Abcam PARP antibody (Abcam, Ab32138) was used in immunohistochemistry - frozen section on rat samples at 1:50. Mol Vis (2014) ncbi
domestic rabbit monoclonal
  • western blot; human; loading ...; fig 3e
Abcam PARP antibody (Abcam, ab32071) was used in western blot on human samples (fig 3e). J Cell Biochem (2015) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry - frozen section; mouse; 2 ug/ml
In order to study mechanisms regulating SOCS expression during viral infection, Abcam PARP antibody (Abcam, ab32064) was used in immunohistochemistry - frozen section on mouse samples at 2 ug/ml. J Virol (2014) ncbi
domestic rabbit monoclonal (Y34)
  • immunohistochemistry - frozen section; fruit fly ; 1:100
In order to mapped age-dependent neuronal changes of caspases in the adult brain throughout the lifespan of Drosophila, Abcam PARP antibody (Abcam, ab32561) was used in immunohistochemistry - frozen section on fruit fly samples at 1:100. PLoS Genet (2014) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry - paraffin section; fruit fly ; 1:1500
Abcam PARP antibody (Abcam, ab32064) was used in immunohistochemistry - paraffin section on fruit fly samples at 1:1500. Hum Mol Genet (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 2e
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig 2e). Mol Cancer (2020) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 3c
Santa Cruz Biotechnology PARP antibody (Santa cruz, F2) was used in western blot on human samples (fig 3c). PLoS Pathog (2019) ncbi
mouse monoclonal (F-2)
  • western blot; mouse; loading ...; fig s13h
Santa Cruz Biotechnology PARP antibody (SCBT, 8007) was used in western blot on mouse samples (fig s13h). Science (2019) ncbi
mouse monoclonal (194C1439)
  • western blot; human; loading ...; fig 10
Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology,, sc-56196) was used in western blot on human samples (fig 10). Biomolecules (2019) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology PARP antibody (Santa Cruz, F-2) was used in western blot on human samples (fig 3a). PLoS ONE (2019) ncbi
mouse monoclonal (F-2)
  • western blot; mouse; loading ...; fig 1b
Santa Cruz Biotechnology PARP antibody (Santa, E-8) was used in western blot on mouse samples (fig 1b). Cell Death Dis (2019) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; loading ...; fig 2a
Santa Cruz Biotechnology PARP antibody (SantaCruz, sc-8007) was used in western blot on human samples at 1:1000 (fig 2a). Cell Rep (2018) ncbi
mouse monoclonal (D-1)
  • chromatin immunoprecipitation; human; loading ...; fig s4b
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-365315) was used in chromatin immunoprecipitation on human samples (fig s4b). Nat Commun (2018) ncbi
mouse monoclonal (F-2)
  • immunoprecipitation; mouse; 1:1000; loading ...; fig 1b
  • western blot; mouse; 1:1000; loading ...; fig 1b
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in immunoprecipitation on mouse samples at 1:1000 (fig 1b) and in western blot on mouse samples at 1:1000 (fig 1b). Cell Death Differ (2018) ncbi
mouse monoclonal (C2-10)
  • western blot; human; fig 7d
Santa Cruz Biotechnology PARP antibody (SantaCruz, sc-53643) was used in western blot on human samples (fig 7d). Cell (2018) ncbi
mouse monoclonal (C2-10)
  • western blot; mouse; fig s5e
Santa Cruz Biotechnology PARP antibody (SantaCruz, sc-53643) was used in western blot on mouse samples (fig s5e). Cell (2018) ncbi
mouse monoclonal (194C1439)
  • western blot; human; fig 5f
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56,196) was used in western blot on human samples (fig 5f). BMC Cancer (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 3f
Santa Cruz Biotechnology PARP antibody (SantaCruz, SC-8007) was used in western blot on human samples (fig 3f). Oncotarget (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; loading ...; fig 5n
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:1000 (fig 5n). Gut (2018) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 2e
Santa Cruz Biotechnology PARP antibody (SantaCruz, SC-8007) was used in western blot on human samples (fig 2e). Mol Cell Biol (2017) ncbi
mouse monoclonal (42)
  • western blot; human; 1:2500; loading ...; fig 4C
Santa Cruz Biotechnology PARP antibody (Santa cruz, sc-136208) was used in western blot on human samples at 1:2500 (fig 4C). Mol Med Rep (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 1d
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig 1d). Oncotarget (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology PARP antibody (Santa Cruz, 8007) was used in western blot on human samples (fig 2c). Nucleic Acids Res (2017) ncbi
mouse monoclonal (C2-10)
  • western blot; human; loading ...; fig 4c
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, sc-53643) was used in western blot on human samples (fig 4c). Cell Death Dis (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; loading ...; fig s4a
In order to analyze the effect of CX-5461 as a G-quadruplex DNA stabilizer, Santa Cruz Biotechnology PARP antibody (Santa CruZ, SC-8007) was used in western blot on human samples at 1:1000 (fig s4a). Nat Commun (2017) ncbi
mouse monoclonal (5A5)
  • western blot; human; loading ...; fig 5f
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56197) was used in western blot on human samples (fig 5f). PLoS Pathog (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; loading ...; fig 6d
In order to examine if SMSr-SAM is structurally and functionally related to the SAM domain of diacylglycerol kinase DGKd, Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc8007) was used in western blot on human samples at 1:1000 (fig 6d). Sci Rep (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 4c
Santa Cruz Biotechnology PARP antibody (SantaCruz, sc8007) was used in western blot on human samples (fig 4c). Expert Opin Ther Targets (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 6e
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig 6e). Oncotarget (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 4h
Santa Cruz Biotechnology PARP antibody (SantaCruz, sc-8007) was used in western blot on human samples (fig 4h). PLoS ONE (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 5b
Santa Cruz Biotechnology PARP antibody (Santa Cruz, SC-8007) was used in western blot on human samples (fig 5b). Oncotarget (2016) ncbi
mouse monoclonal (F-2)
  • western blot; mouse; loading ...; fig 5
In order to discuss targeting mTOR-signaling and lactate dehydrogenase A as a strategy to treat colorectal cancer, Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on mouse samples (fig 5). J Cancer (2016) ncbi
mouse monoclonal (E-8)
  • immunocytochemistry; human; fig 1
In order to assess the effects of combining PARP-1 inhibition with carbon ion exposure to control metastatic cells, Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-74469) was used in immunocytochemistry on human samples (fig 1). Radiat Oncol (2016) ncbi
mouse monoclonal (194C1439)
  • western blot; human; fig 5
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56196) was used in western blot on human samples (fig 5). Mol Med Rep (2016) ncbi
mouse monoclonal (F-2)
  • western blot; mouse; 1:500; loading ...; fig 4c
In order to test if alpha7nAChR in adipocytes may inhibit acylation stimulating protein-induced inflammation, Santa Cruz Biotechnology PARP antibody (Santa cruz, sc-8007) was used in western blot on mouse samples at 1:500 (fig 4c). Mol Med Rep (2016) ncbi
mouse monoclonal (E-8)
  • western blot; human; fig 2
Santa Cruz Biotechnology PARP antibody (santa Cruz, sc-74469) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (194C1439)
  • western blot; human; fig 3
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56196) was used in western blot on human samples (fig 3). Onco Targets Ther (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:500; fig 4
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Santa Cruz Biotechnology PARP antibody (Santa Cruz, Sc-8007) was used in western blot on human samples at 1:500 (fig 4). Future Oncol (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; fig 3
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:1000 (fig 3). Mol Med Rep (2016) ncbi
mouse monoclonal (194C1439)
  • western blot; rat; 1:1000; fig 4
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56196) was used in western blot on rat samples at 1:1000 (fig 4). Exp Ther Med (2016) ncbi
mouse monoclonal (10H)
  • immunoprecipitation; fruit fly ; fig 4
Santa Cruz Biotechnology PARP antibody (santa Cruz, sc-56198) was used in immunoprecipitation on fruit fly samples (fig 4). PLoS Genet (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 2c
Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, sc-8007) was used in western blot on human samples (fig 2c). PLoS ONE (2016) ncbi
mouse monoclonal (C2-10)
  • immunocytochemistry; mouse; fig 4
  • western blot; mouse; 1:1000; fig s4
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-53643) was used in immunocytochemistry on mouse samples (fig 4) and in western blot on mouse samples at 1:1000 (fig s4). Nat Commun (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 4
Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, sc8007) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; fig s1
In order to assess the interference of HCV replication through the autolysosomal degradation of NS5A by the interferon-inducible protein SCOTIN, Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 1c
Santa Cruz Biotechnology PARP antibody (SantaCruz, sc-8007) was used in western blot on human samples (fig 1c). Mol Cell Biol (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 1
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig 1). Oxid Med Cell Longev (2016) ncbi
mouse monoclonal (194C1439)
  • western blot; human; 1:500; fig 4
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56196) was used in western blot on human samples at 1:500 (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (F-2)
  • immunohistochemistry - paraffin section; human; fig st1
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in immunohistochemistry - paraffin section on human samples (fig st1). PLoS ONE (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 1c
In order to investigate the role of mitochondrial ATR during the response to UV damage, Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, sc-8007) was used in western blot on human samples (fig 1c). Mol Cell (2015) ncbi
mouse monoclonal (5A5)
  • western blot; human; fig 4
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56197) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 4
Santa Cruz Biotechnology PARP antibody (Santa, sc-8007) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (10H)
  • western blot; human; loading ...; fig 4
Santa Cruz Biotechnology PARP antibody (Santa, sc-56198) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig st2
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig st2). Oncotarget (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 6
In order to study the role of transmembrane protein 33 in the unfolded protein response, Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, F-2) was used in western blot on human samples (fig 6). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (5A5)
  • western blot; human; fig 2
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56197) was used in western blot on human samples (fig 2). Acta Pharmacol Sin (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:2000; fig 6
Santa Cruz Biotechnology PARP antibody (Santa Cruz, SC- 8007) was used in western blot on human samples at 1:2000 (fig 6). Melanoma Res (2015) ncbi
mouse monoclonal (D-1)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-365315) was used in western blot on human samples (fig 4a). Sci Rep (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 2
Santa Cruz Biotechnology PARP antibody (santa Cruz, sc-8007) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (C2-10)
  • western blot; human; fig 5C
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-53643) was used in western blot on human samples (fig 5C). Oncotarget (2015) ncbi
mouse monoclonal (194C1439)
  • western blot; human; 1:200; fig 6
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56196) was used in western blot on human samples at 1:200 (fig 6). Sci Rep (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human
In order to study myocardial infarction-induced cardiomyocyte apoptosis in the context of sialylation of heart, Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, SC-8007) was used in western blot on human samples . Basic Res Cardiol (2015) ncbi
mouse monoclonal (3H2844)
  • western blot; rat; fig 1
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-71848) was used in western blot on rat samples (fig 1). Neurotox Res (2015) ncbi
mouse monoclonal (194C1439)
  • western blot; human; 1:200; fig 1c
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-56196) was used in western blot on human samples at 1:200 (fig 1c). Nat Commun (2015) ncbi
mouse monoclonal (B-10)
  • western blot; human
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-74470) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (B-10)
  • western blot; human; fig 3a
Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, sc-74470) was used in western blot on human samples (fig 3a). Nucleic Acids Res (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples . Mol Cancer Res (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig s3
Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnologies, sc8007) was used in western blot on human samples (fig s3). Oncogene (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:500
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:500. Cancer Cell (2014) ncbi
mouse monoclonal (F-2)
  • western blot; human
In order to determine if inhibition of AKT signaling augments erlotinib activity and abrogates HGF-mediated resistance, Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, sc-8007) was used in western blot on human samples . J Cancer Res Clin Oncol (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (E-8)
  • chromatin immunoprecipitation; mouse; loading ...; fig s6a
  • immunocytochemistry; mouse; loading ...; fig 1e
Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, sc-74469x) was used in chromatin immunoprecipitation on mouse samples (fig s6a) and in immunocytochemistry on mouse samples (fig 1e). Nucleic Acids Res (2014) ncbi
mouse monoclonal (D-1)
  • western blot; human; fig 7
Santa Cruz Biotechnology PARP antibody (Santa Cruz Biotechnology, SC-365315) was used in western blot on human samples (fig 7). Br J Nutr (2014) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000
Santa Cruz Biotechnology PARP antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:1000. Nucleic Acids Res (2011) ncbi
Enzo Life Sciences
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1f
Enzo Life Sciences PARP antibody (Enzo, ALX-210-302) was used in western blot on human samples (fig 1f). MBio (2018) ncbi
mouse monoclonal (F1-23)
  • western blot; human; 1:1000; loading ...; fig 5a
Enzo Life Sciences PARP antibody (Alexis Biochemicals, ALX-804-211) was used in western blot on human samples at 1:1000 (fig 5a). Nucleic Acids Res (2018) ncbi
mouse monoclonal (C-2-10)
  • western blot; mouse; fig 2
Enzo Life Sciences PARP antibody (Enzo, BML-SA249) was used in western blot on mouse samples (fig 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 3b
Enzo Life Sciences PARP antibody (Enzo, BML-SA253) was used in western blot on human samples at 1:2000 (fig 3b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 3b
Enzo Life Sciences PARP antibody (Enzo, BML-SA253) was used in western blot on human samples at 1:2000 (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; 1:1000; fig 6
Enzo Life Sciences PARP antibody (Biomol, SA250) was used in western blot on human samples at 1:1000 (fig 6). Biochem Pharmacol (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; 1:3000; fig 1a
Enzo Life Sciences PARP antibody (Enzo, BML-SA250) was used in western blot on human samples at 1:3000 (fig 1a). Mol Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6a
Enzo Life Sciences PARP antibody (Alexis, 210-302-R100) was used in western blot on human samples (fig 6a). PLoS Pathog (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; fig 3
Enzo Life Sciences PARP antibody (Enzo Life Sciences, C-2-10) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; loading ...; fig 5b
Enzo Life Sciences PARP antibody (Enzo, C-2-10) was used in western blot on human samples (fig 5b). Cell Death Differ (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to determine the action of PARP inhibition in different glioblastoma multiforme cell lines, Enzo Life Sciences PARP antibody (ALEXIS, C2-10) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; fig 3
In order to analyze ABT737 resistance in squamous cell carcinoma of the skin determined by the ratio of Mcl-1 and Noxa, Enzo Life Sciences PARP antibody (Biomol, C-2-10) was used in western blot on human samples (fig 3). Cell Death Dis (2014) ncbi
mouse monoclonal (C-2-10)
  • western blot; mouse
  • western blot; human; fig 3
Enzo Life Sciences PARP antibody (Enzo, BML-SA250) was used in western blot on mouse samples and in western blot on human samples (fig 3). J Biol Chem (2014) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; 1:1000
Enzo Life Sciences PARP antibody (Enzo, BML-SA250) was used in western blot on human samples at 1:1000. PLoS Pathog (2013) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to study the mechanism for enterovirulence of Escherichia coli strain C1845, Enzo Life Sciences PARP antibody (Enzo Life Sciences, C2-10) was used in western blot on human samples . Infect Immun (2010) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
Enzo Life Sciences PARP antibody (Biomol, C-2-10) was used in western blot on human samples . J Neurooncol (2010) ncbi
mouse monoclonal (F1-23)
  • immunoprecipitation; human
Enzo Life Sciences PARP antibody (Alexis Biochemicals, F1-23) was used in immunoprecipitation on human samples . J Biol Chem (2009) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
Enzo Life Sciences PARP antibody (Alexis Biochemicals, C2-10) was used in western blot on human samples . J Biol Chem (2009) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to examine the hepatotoxicity of TRAIL/bortezomib cotreatment, Enzo Life Sciences PARP antibody (Biomol, C-2-10) was used in western blot on human samples . Hepatology (2007) ncbi
mouse monoclonal (C-2-10)
  • western blot; rhesus macaque
In order to study the activation of Bax during rotavirus-induced apoptosis, Enzo Life Sciences PARP antibody (Biomol, C-2-10) was used in western blot on rhesus macaque samples . J Virol (2007) ncbi
Invitrogen
domestic rabbit monoclonal (C.384.8)
  • western blot; human; loading ...; fig 4c
Invitrogen PARP antibody (pierce, MA5-15031) was used in western blot on human samples (fig 4c). Front Genet (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; loading ...; fig 5c
In order to explore the use of bacterial carriers in a rat model of glioblastoma, Invitrogen PARP antibody (Thermo Fisher, 44-698G) was used in immunohistochemistry - paraffin section on rat samples (fig 5c). Mol Ther Oncolytics (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 6
In order to study the generation of homogenous three-dimensional pancreatic cancer cell spheroids and their improved hanging drop technique, Invitrogen PARP antibody (Thermo Fisher, PA5-16452) was used in immunohistochemistry - paraffin section on human samples (fig 6). Tissue Eng Part C Methods (2016) ncbi
mouse monoclonal (123)
  • western blot; human; fig 3
In order to report that USP17 interacts with HDAC2, Invitrogen PARP antibody (Invitrogen, 436400) was used in western blot on human samples (fig 3). Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (123)
  • western blot; human; fig 3
In order to investigate how IL-33 regulates IL-13 gene expression, Invitrogen PARP antibody (Invitrogen, 436400) was used in western blot on human samples (fig 3). Int J Mol Sci (2015) ncbi
mouse monoclonal (123)
  • western blot; human; fig 1
In order to study the involvement of TIMELESS in the PARP1-mediated DNA damage response, Invitrogen PARP antibody (Invitrogen, 436400) was used in western blot on human samples (fig 1). Cell Rep (2015) ncbi
mouse monoclonal (123)
  • immunoprecipitation; human; fig 1
In order to study the effect of ubiquitination modification in regulating the protein stability and the nuclear function of IL-33, Invitrogen PARP antibody (Invitrogen, 436400) was used in immunoprecipitation on human samples (fig 1). Int J Clin Exp Pathol (2014) ncbi
mouse monoclonal (C-2-10)
  • immunohistochemistry - paraffin section; human; 1:1500
  • western blot; human; 1:1500
In order to study the involvement of decreased parkin solubility and reduced nigrostriatum autophagy in sporadic Parkinson's disease, Invitrogen PARP antibody (Pierce, MA3-950) was used in immunohistochemistry - paraffin section on human samples at 1:1500 and in western blot on human samples at 1:1500. Neuroscience (2013) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to investigate the interaction between HOXB7 and poly (ADP-ribose) polymerase-1, Invitrogen PARP antibody (Invitrogen, C-2-10) was used in western blot on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to investigate the cellular localization and function of negative transcription elongation factor , Invitrogen PARP antibody (Affinity Bioreagents, MA3-950) was used in western blot on human samples . Exp Cell Res (2009) ncbi
mouse monoclonal (C-2-10)
  • western blot; mouse; 1:1000; fig 1A
In order to characterize defects in harlequin mutant mice, Invitrogen PARP antibody (Zymed, C-2-10) was used in western blot on mouse samples at 1:1000 (fig 1A). Cell Death Differ (2007) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; fig 2
In order to identify pathways that are constitutively activated in a KIT-dependent manner in gastrointestinal stromal tumors, Invitrogen PARP antibody (Zymed, C-2-10) was used in western blot on human samples (fig 2). Oncogene (2004) ncbi
Bio-Rad
mouse monoclonal (A6.4.12)
  • western blot; human; loading ...; fig 4b
In order to investigate the role of XRCC1 protein complexes in normal neurological function and identify PARP1 as a therapeutic target in DNA strand break repair-defective disease, Bio-Rad PARP antibody (Serotec, MCA1522G) was used in western blot on human samples (fig 4b). Nature (2017) ncbi
mouse monoclonal (A6.4.12)
  • western blot knockout validation; human; loading ...; fig 1a
  • immunohistochemistry; human; loading ...; fig 1b
In order to investigate the roles of PARP2 and PARP3 during DNA break repair, Bio-Rad PARP antibody (Serotec, MCA1522G) was used in western blot knockout validation on human samples (fig 1a) and in immunohistochemistry on human samples (fig 1b). Nucleic Acids Res (2017) ncbi
mouse monoclonal (A6.4.12)
  • western blot; human; 1:1000; fig 3
Bio-Rad PARP antibody (Bio-Rad, MCA1522G) was used in western blot on human samples at 1:1000 (fig 3). Nucleic Acids Res (2015) ncbi
mouse monoclonal (A6.4.12)
  • immunocytochemistry; rat; 1:500
Bio-Rad PARP antibody (AbD Serotec, MCA1522G) was used in immunocytochemistry on rat samples at 1:500. PLoS ONE (2014) ncbi
LifeSpan Biosciences
mouse monoclonal (A6.4.12)
  • western blot; human; loading ...; fig 5c, 7e
LifeSpan Biosciences PARP antibody (Nordic Biosite, LS-B3432) was used in western blot on human samples (fig 5c, 7e). Nucleic Acids Res (2019) ncbi
Active Motif
domestic rabbit polyclonal
  • proximity ligation assay; human; fig 7
In order to study regulation by ADP-ribosylation of bone morphogenetic protein signaling, Active Motif PARP antibody (Active Motif, 39559) was used in proximity ligation assay on human samples (fig 7). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 6
In order to elucidate modulation of gene expression in pluripotent cells by SOX2 O-GlcNAcylation altering protein-protein interactions and genomic occupancy, Active Motif PARP antibody (ActiveMotif, 39559) was used in western blot on mouse samples (fig 6). elife (2016) ncbi
Abnova
mouse monoclonal (A6.4.12)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 1
In order to analyze the significance biologically and clinically of PARP1 protein expression in breast cancer, Abnova PARP antibody (Abnova, A6.4.12) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1). Breast Cancer Res Treat (2015) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 2a). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples (fig 2a). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625S) was used in western blot on human samples (fig 3d). Cell Rep (2021) ncbi
domestic rabbit monoclonal (46D11)
  • immunocytochemistry knockout validation; human; 1:1000; loading ...; fig 2a
  • western blot knockout validation; human; 1:1000; loading ...; fig s3c
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Cell Signaling Technology PARP antibody (CST, 46D11) was used in immunocytochemistry knockout validation on human samples at 1:1000 (fig 2a), in western blot knockout validation on human samples at 1:1000 (fig s3c) and in immunohistochemistry - paraffin section on human samples (fig 4a). Molecules (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:400; loading ...; fig 5d
Cell Signaling Technology PARP antibody (Cell signaling, 9542S) was used in western blot on mouse samples at 1:400 (fig 5d). Nat Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples (fig 2b). Cell Commun Signal (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 6f
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6f). Cells (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 6c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 6c). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 3b
  • western blot; human; loading ...; fig 6e
Cell Signaling Technology PARP antibody (CST, 9542) was used in western blot on mouse samples (fig 3b) and in western blot on human samples (fig 6e). Sci Rep (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 5c). Oncol Rep (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 6b). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2e
Cell Signaling Technology PARP antibody (Cell Signalling Technology, 9542) was used in western blot on human samples at 1:1000 (fig 2e). elife (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 2a). BMC Complement Med Ther (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology PARP antibody (Cell Signaling, 9532S) was used in western blot on human samples (fig 5b). Cancers (Basel) (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 7a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 7a). elife (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532S) was used in western blot on human samples (fig 1c). Cancer Res (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3e, 4e, 5e
Cell Signaling Technology PARP antibody (Cell Signaling Technology, Inc., #9542) was used in western blot on human samples at 1:1000 (fig 3e, 4e, 5e). Chem Biol Drug Des (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2500; fig 1a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:2500 (fig 1a). Oncogene (2020) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; mouse; 1:1000; loading ...; fig 3d
Cell Signaling Technology PARP antibody (Cell Signaling Technology, #5625) was used in western blot on mouse samples at 1:1000 (fig 3d). EBioMedicine (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; loading ...; fig 3d
Cell Signaling Technology PARP antibody (Cell Signaling Technology, #9532) was used in western blot on mouse samples at 1:1000 (fig 3d). EBioMedicine (2020) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 4a
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on rat samples at 1:1000 (fig 4a). Br J Pharmacol (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 5c). Sci Adv (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology PARP antibody (CST, 9542) was used in western blot on human samples (fig 4b). FASEB Bioadv (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4i
Cell Signaling Technology PARP antibody (Cell signaling Technology, 9542) was used in western blot on human samples (fig 4i). Mol Cancer (2020) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; mouse; 1:1000; loading ...; fig 2f
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on mouse samples at 1:1000 (fig 2f). Biosci Rep (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1b
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples (fig 1b). Oncogenesis (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s7c
Cell Signaling Technology PARP antibody (CST, 9544S) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s7c). Life Sci Alliance (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 3c). Cancer Cell Int (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3d). J Cancer (2020) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3d). J Cancer (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology PARP antibody (CST, 46D11) was used in western blot on human samples (fig 4g). EBioMedicine (2020) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples . Nature (2020) ncbi
domestic rabbit monoclonal (D64E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7h
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in immunohistochemistry - paraffin section on human samples (fig 7h). Nat Commun (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 6e
Cell Signaling Technology PARP antibody (CST, 9532) was used in western blot on human samples at 1:1000 (fig 6e). Genes Cancer (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 5d). Oncogene (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig s5a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig s5a). J Exp Med (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1c, s3b, s3c, s3d
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples at 1:1000 (fig 1c, s3b, s3c, s3d). Oncogene (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig s3f
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:2000 (fig s3f). Oncogene (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 2g
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 2g). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9541) was used in western blot on human samples . Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542S) was used in western blot on human samples (fig 5c). Mod Pathol (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 7b). Cell (2019) ncbi
mouse monoclonal (19F4)
  • western blot; human; loading ...; fig 3e
Cell Signaling Technology PARP antibody (CST, 9546) was used in western blot on human samples (fig 3e). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7f
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 7f). Cancer Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples at 1:1000 (fig 4a). EMBO Mol Med (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 4a). EMBO Mol Med (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6b). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 4f). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig s2a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig s2a). Cell (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6a). elife (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • immunohistochemistry; human; loading ...; fig 6a
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in immunohistochemistry on human samples (fig 6a) and in western blot on human samples (fig 6a). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology PARP antibody (Cell Signalling Technology, 9542) was used in western blot on human samples (fig 4d). J Cell Mol Med (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 4d
Cell Signaling Technology PARP antibody (Cell Signalling Technology, 5625) was used in western blot on human samples at 1:1000 (fig 4d). EMBO Mol Med (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 4d
Cell Signaling Technology PARP antibody (Cell Signalling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 4d). EMBO Mol Med (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s8e
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9541) was used in western blot on human samples (fig s8e). Sci Adv (2019) ncbi
mouse monoclonal (7C9)
  • western blot; mouse; loading ...; fig s2d
Cell Signaling Technology PARP antibody (Cell Signaling, 9548) was used in western blot on mouse samples (fig s2d). Science (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig s2d
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig s2d). Science (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 3b). Int J Oncol (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 4c). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2e
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2e). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology PARP antibody (CST, 9532) was used in western blot on human samples (fig 1c). BMC Cancer (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig e8d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig e8d). Nature (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625S) was used in western blot on human samples at 1:1000 (fig 3a). Biochem Biophys Res Commun (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6f
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 6f). Front Mol Neurosci (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 4c). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig s1a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig s1a). Breast Cancer Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1a
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig s1a). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 8f
Cell Signaling Technology PARP antibody (Cell signaling, 5625) was used in western blot on human samples (fig 8f). elife (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 4c). Br J Cancer (2019) ncbi
mouse monoclonal (19F4)
  • western blot; human; 1:1000; loading ...; fig 2d
Cell Signaling Technology PARP antibody (Cell Signaling, 9546S) was used in western blot on human samples at 1:1000 (fig 2d). Cell Death Differ (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 7a). Exp Cell Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9541) was used in western blot on human samples (fig 2c). Cell Death Dis (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1b). Nature (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples (fig 5a). Toxicology (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1d). Genes Dev (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 7d). Oncogene (2019) ncbi
mouse monoclonal (7C9)
  • western blot; mouse; 1:1000; loading ...; fig 1g
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9548S) was used in western blot on mouse samples at 1:1000 (fig 1g). elife (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 5f
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig 5f). Oncogene (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig s1a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig s1a). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1s1b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1s1b). elife (2018) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3s1c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3s1c). elife (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig s1
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig s1). Methods (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 4a, 4b, 4c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples at 1:1000 (fig 4a, 4b, 4c). Oncogene (2019) ncbi
mouse monoclonal (7C9)
  • western blot; mouse; loading ...; fig 5e
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9548) was used in western blot on mouse samples (fig 5e). FASEB J (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s4g
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:1000 (fig s4g). Nat Cell Biol (2018) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; mouse; loading ...; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on mouse samples (fig 4c). Mol Cell Biochem (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling, 9544s) was used in western blot on mouse samples (fig 4c). Mol Cell Biochem (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 2g
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 2g). Oncogene (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8g
Cell Signaling Technology PARP antibody (Cell Signaling, 9542L) was used in western blot on human samples at 1:1000 (fig 8g). EMBO J (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig s15a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532S) was used in western blot on human samples (fig s15a). J Clin Invest (2018) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig s15a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625S) was used in western blot on human samples (fig s15a). J Clin Invest (2018) ncbi
mouse monoclonal (7C9)
  • western blot; human; loading ...; fig s4
Cell Signaling Technology PARP antibody (Cell Signaling, 9548) was used in western blot on human samples (fig s4). Oncogene (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s4
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig s4). Oncogene (2019) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig s7b
Cell Signaling Technology PARP antibody (Cell Signaling, 5625P) was used in western blot on human samples (fig s7b). Science (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 4e
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples (fig 4e). Cell Death Dis (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 2c). Nat Med (2018) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 8b
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples (fig 8b). Autophagy (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 1j
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 1j). Nat Cell Biol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s3a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig s3a). J Clin Invest (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2c). Front Immunol (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 2a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig 2a). Life Sci (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3d
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 3d). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 2b
Cell Signaling Technology PARP antibody (Cell Signaling, 9544) was used in western blot on mouse samples (fig 2b). Cell Signal (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on mouse samples (fig 1d). Cell Mol Immunol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3g
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 3g). Nat Med (2018) ncbi
mouse monoclonal (19F4)
  • western blot; human; 1:1000; loading ...; fig 1e
Cell Signaling Technology PARP antibody (Cell Signaling, 9546) was used in western blot on human samples at 1:1000 (fig 1e). Science (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig 5a). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 9b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 9b). Int J Biochem Cell Biol (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2e
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2e). Cell (2018) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 2e
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 2e). Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3b
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 3b). Cell (2018) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 5h
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 5h). Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1i
  • western blot; human; loading ...; fig 1i
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on mouse samples (fig 1i) and in western blot on human samples (fig 1i). J Clin Invest (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4c
Cell Signaling Technology PARP antibody (Cell signaling, 9541) was used in western blot on human samples (fig 4c). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 4c). Neoplasia (2018) ncbi
mouse monoclonal (7C9)
  • western blot; mouse; loading ...; fig 6d
Cell Signaling Technology PARP antibody (Cell Signaling, 9548) was used in western blot on mouse samples (fig 6d). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s4f
Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig s4f). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology PARP antibody (Cell Signalling, 9532) was used in western blot on mouse samples (fig 3a). J Mol Biol (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2b). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2b). Tumour Biol (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:500; loading ...; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:500 (fig 4c). Cell Death Dis (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3a). Clin Cancer Res (2018) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3a). Clin Cancer Res (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; loading ...; fig 1h
In order to study induction of cell death by low frequency magnetic fields, Cell Signaling Technology PARP antibody (Cell Signalling, 9532) was used in western blot on mouse samples at 1:1000 (fig 1h). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1b). Oncogene (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; fig 1a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples at 1:1000 (fig 1a). Nat Cell Biol (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig s9b
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig s9b). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig s9b
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig s9b). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 4f). Oncogene (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • immunocytochemistry; human; 1:400; loading ...; fig s5b
In order to investigate the effect of actomyosin on cell nuclear morphology and genome stability, Cell Signaling Technology PARP antibody (Cell Signalling Tech, 5625) was used in immunocytochemistry on human samples at 1:400 (fig s5b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 9a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 9a). J Cell Biol (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 4i
Cell Signaling Technology PARP antibody (Cell signaling, 5625) was used in western blot on human samples (fig 4i). Leuk Lymphoma (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig 1d). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples at 1:1000 (fig 5a). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 1c
In order to understand the interaction between PTEN and FBXL2 in the context of apoptosis, Cell Signaling Technology PARP antibody (Cell Signaling, 5625S) was used in western blot on human samples (fig 1c). Nature (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1d
Cell Signaling Technology PARP antibody (Cell signal, 9542s) was used in western blot on human samples (fig s1d). Nature (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s5f
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig s5f). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1d
Cell Signaling Technology PARP antibody (Cell signal, 9542s) was used in western blot on human samples (fig s1d). Nature (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 2b
In order to study the role of TRAPPC13 in autophagy and the cellular response to Golgi stress, Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples at 1:1000 (fig 2b). J Cell Sci (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5d
In order to understand the role of nicotinamide metabolism in the maintenance of glioblastoma stem cells, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples (fig 5d). JCI Insight (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s5
Cell Signaling Technology PARP antibody (Cell signaling, 9541) was used in western blot on human samples (fig s5). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig s6a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig s6a). Mol Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s5b
In order to study the effect of GNAQ mutations and GNA11/MAPK pathway activation in uveal melanoma, Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig s5b). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s5b
In order to study the effect of GNAQ mutations and GNA11/MAPK pathway activation in uveal melanoma, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig s5b). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 5e
Cell Signaling Technology PARP antibody (Cell signaling, 5625) was used in western blot on human samples at 1:1000 (fig 5e). Biochem Pharmacol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5e
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 5e). Biochem Pharmacol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 11c
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples (fig 11c). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6c
Cell Signaling Technology PARP antibody (CST, 9541) was used in western blot on human samples (fig 6c). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s3a
In order to show that PHB1 is highly expressed in non-small cell lung cancers patients and correlates with poor survival, Cell Signaling Technology PARP antibody (Cell Signalling, 9542) was used in western blot on human samples (fig s3a). Oncogene (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 2d
In order to determine that SIRT1 is functionally required for sustaining the proliferation and survival of primary effusion lymphoma cells, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples (fig 2d). J Pathol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2
Cell Signaling Technology PARP antibody (cell signalling, 9542) was used in western blot on human samples (fig 2). Neoplasia (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • immunohistochemistry; human; 1:50; loading ...; fig 7
Cell Signaling Technology PARP antibody (cell signalling, 5625) was used in immunohistochemistry on human samples at 1:50 (fig 7). Neoplasia (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 7a
In order to study the synergistic antitumor effect of simultaneously targeting CD47 and autophagy in non-small cell lung cancer, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 7a). Cancer Immunol Res (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 7c
Cell Signaling Technology PARP antibody (cell signalling, 5625) was used in western blot on human samples at 1:1000 (fig 7c). Int J Oncol (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; mouse; 1:500; fig 6a
In order to examine the impact of the unfolded protein response in satellite cell homeostasis during regenerative myogenesis, Cell Signaling Technology PARP antibody (Cell signaling, 5625P) was used in western blot on mouse samples at 1:500 (fig 6a). elife (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 1c). Sci Rep (2017) ncbi
mouse monoclonal (19F4)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology PARP antibody (CST, 9546) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 2g
In order to analyze the contributions of developmental Hedgehog signaling effectors HDAC1 and HDAC2 in SHH Medulloblastoma, Cell Signaling Technology PARP antibody (Cell Signaling, 9542 S) was used in western blot on mouse samples at 1:1000 (fig 2g). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3k, 5i, 6f
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on mouse samples at 1:1000 (fig 3k, 5i, 6f). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology PARP antibody (Cell signalling, 5625) was used in western blot on human samples (fig 1f). Cancer Lett (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
Cell Signaling Technology PARP antibody (CST, 9542) was used in western blot on human samples . Mol Ther (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology PARP antibody (Cell Signalling, 9542) was used in western blot on human samples (fig 4d). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples at 1:1000 (fig 1a). Mol Cell Biol (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 7a
Cell Signaling Technology PARP antibody (Cell signaling Technology, 9544) was used in western blot on mouse samples at 1:500 (fig 7a). Cell Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 1c). Sci Rep (2017) ncbi
mouse monoclonal (7C9)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology PARP antibody (Cell Signaling, 9548) was used in western blot on human samples (fig 3a). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples at 1:1000 (fig 1b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 6b
In order to elucidate that mTORC1 presents tumor suppressor features in conditions of nutrient restrictions, Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples at 1:1000 (fig 6b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 2a, 2b
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 2a, 2b). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 2a
In order to determine that Krupple-like factor 10 silencing correlates with enhanced pancreatic cancer clonogenic survival and murine tumor growth after radiation, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 2a). Radiother Oncol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1g
In order to find AURKA activity as essential in non-small cell lung cancer cells lacking SMARCA4/BRG1, Cell Signaling Technology PARP antibody (Cell signaling, 9541) was used in western blot on human samples at 1:1000 (fig 1g). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8b
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:1000 (fig 8b). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • flow cytometry; human; 1:800; fig s1
In order to determine the expression of somatostatin receptors in Von Hippel-Lindau-associated hemangioblastomas, Cell Signaling Technology PARP antibody (Cell Signaling, 5625 S) was used in flow cytometry on human samples at 1:800 (fig s1). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 8c
In order to show that quercetin inhibits the PI3K/AKT/mTOR and STAT3 pathways in primary effusion lymphoma, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:500 (fig 8c). J Nutr Biochem (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6a
In order to quantify changes in cytoplasmic and mitochondrial interactomes in response to apoptosis initiation as a function of caspase activity, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6a). Mol Syst Biol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1k
In order to show that the deoxynucleoside triphosphate triphosphohydrolase SAM domain and HD domain 1 promotes the detoxification of intracellular cytostatic deoxycytidine analog cytarabine triphosphate pools, Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 1k). Nat Med (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2a
In order to propose a new role for PACS1 as a regulator of the intrinsic pathway of apoptosis and mitochondrial outer membrane permeabilization, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2a). Cell Death Differ (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 4a). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples at 1:1000 (fig 4b). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
In order to explore the role of PRKAR2B in castration-resistant prostate cancer, Cell Signaling Technology PARP antibody (Cell signaling, 9541S) was used in western blot on human samples (fig 5a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 2c
In order to explore the impact of SNHG5 in colorectal cancer, Cell Signaling Technology PARP antibody (cell signalling, 5625) was used in western blot on human samples (fig 2c). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • immunocytochemistry; human; loading ...; fig s2
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in immunocytochemistry on human samples (fig s2). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 4c). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 7b
In order to elucidate the regulation and function of enzymatically inactive heparanase, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on rat samples (fig 7b). Cardiovasc Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3d
In order to report that cathepsin S inhibition sensitizes cancer cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis, Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 3d). Antioxid Redox Signal (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 1d). Mol Cancer Ther (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7g
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 7g). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625S) was used in western blot on human samples at 1:1000 (fig 2c). Int J Oncol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542S) was used in western blot on human samples at 1:1000 (fig 2c). Int J Oncol (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3h
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3h). Exp Hematol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d
In order to examine the effects of curcumin treatment on myeloid leukemia cells, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 4d). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 3c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3c). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3c
In order to elucidate the role of HAP40 in Huntington's disease, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on mouse samples at 1:1000 (fig 3c). Mol Neurobiol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s5c
In order to identify and characterize an inhibitor of the COP9 signalosome, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig s5c). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
In order to explore the role of the S100A7 in oral squamous cell carcinoma, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3a). Cancer Gene Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2d
In order to elucidate the contribution of MDM2 expression to retinoblastoma tumorigenesis, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:500 (fig 2d). Oncogene (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 1d, 3c
  • western blot; human; loading ...; fig 3a, 1e
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig 1d, 3c) and in western blot on human samples (fig 3a, 1e). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3
Cell Signaling Technology PARP antibody (Cell Signalling, 9532) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
In order to investigate how 6-C-(E-phenylethenyl)naringenin inhibits cancer cell growth, Cell Signaling Technology PARP antibody (Cell signaling, 9541) was used in western blot on human samples (fig 2d). Eur J Cancer (2016) ncbi
mouse monoclonal (19F4)
  • western blot; human; loading ...; fig 1e
In order to characterize autophagy induction by thiopurines, Cell Signaling Technology PARP antibody (Cell signaling, 9546) was used in western blot on human samples (fig 1e). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling, 9532S) was used in western blot on human samples (fig 2c). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625S) was used in western blot on human samples (fig 2c). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3f
In order to elucidate the upstream mechanisms of apoptosis triggered by an anti-microtubule drug, ABT-751, Cell Signaling Technology PARP antibody (cell signalling, 9542) was used in western blot on human samples at 1:1000 (fig 3f). Toxicol Appl Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology PARP antibody (CST, 9542) was used in western blot on human samples (fig 1a). Mol Cell Biol (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:800; loading ...; fig 2a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples at 1:800 (fig 2a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5f
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 5f). Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1e
Cell Signaling Technology PARP antibody (cell signalling, 9542) was used in western blot on human samples at 1:1000 (fig 1e). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology PARP antibody (Cell signaling, 5625) was used in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 1a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7h
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 7h). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 2
In order to elucidate the mechanisms by which mutant IDH1/2 contributes to oncogenesis, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3h
In order to elucidate how FADD contributes to mitochondrial-associated apoptosis, Cell Signaling Technology PARP antibody (Cell Signaling, 9542P) was used in western blot on human samples at 1:1000 (fig 3h). Mol Cell Biochem (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig s2i
In order to discover that ubiquitin-specific protease 7 is a regulator of N-Myc function in neuroblastoma, Cell Signaling Technology PARP antibody (Cell signaling, 9532) was used in western blot on human samples at 1:1000 (fig s2i). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 5b). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 9c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on rat samples at 1:1000 (fig 9c). J Pharmacol Exp Ther (2016) ncbi
mouse monoclonal (19F4)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology PARP antibody (Cell Signaling, 9546) was used in western blot on human samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5B
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 5B). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3c
In order to test if focal adhesion kinase present in rhabdomyosarcoma affect cellular survival, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3c). Transl Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3c
In order to test if focal adhesion kinase present in rhabdomyosarcoma affect cellular survival, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3c). Transl Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3f
In order to report that inhibition of PP2A kills PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3f). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 4b). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s15
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig s15). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1d). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b,5c,6b,6c,6d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 5b,5c,6b,6c,6d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 8a
In order to assess the anticancer properties of 3',4',5'-trimethoxy-5-chloro-isatinylchalcone, Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 8a). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5F
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 5F). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 4a
In order to discover and characterize beta-cell protective agents that prevent endoplasmic reticulum stress-induced dysfunction and death, Cell Signaling Technology PARP antibody (Cell signaling, 9542L) was used in western blot on rat samples at 1:1000 (fig 4a). J Med Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; dogs; 1:1000; fig 3a
In order to investigate how serine proteases increase transepithelial electrical resistance, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on dogs samples at 1:1000 (fig 3a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 1
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples at 1:500 (fig 1). Cell Div (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6a
In order to use knockout mice to determine if RHOX13 contributes to male germ cell differentiation, Cell Signaling Technology PARP antibody (Cell Signaling, 9544) was used in immunohistochemistry on mouse samples at 1:100 (fig 6a). Reproduction (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 6a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology PARP antibody (CST, 9542) was used in western blot on human samples at 1:1000 (fig 1). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 6
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 6). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5d
In order to study how methylation of p53 affects its interactions with other proteins such as PUMA and p300/CBP, Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 5d). Oncogene (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5g
Cell Signaling Technology PARP antibody (cell signalling, 9532) was used in western blot on human samples (fig 5g). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 3d,4b,5e,7b
Cell Signaling Technology PARP antibody (CST, 9541L) was used in western blot on human samples at 1:1000 (fig 3d,4b,5e,7b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5
In order to research differentiation of functional glutamatergic neurons from placenta-derived multipotent cells by knocking down of heat-shock protein 27, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • immunocytochemistry; human; loading ...; fig 4a
In order to assess the importance of the IGF1R tyrosine kinase in triple-negative gastric cancer with and without oncogenic KRAS, BRAF or PI3K3CA mutations, Cell Signaling Technology PARP antibody (Cell signaling, 6894) was used in immunocytochemistry on human samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on mouse samples (fig 1). Mol Cancer Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4c
In order to examine the role of topoisomerase II in mitotic clonal expansion and adipogenesis, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig 4c). Cell Signal (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...
In order to study factors that influence the expansion and movement of primordial germ cells, Cell Signaling Technology PARP antibody (Cell Signaling, 9544s) was used in immunohistochemistry - frozen section on mouse samples at 1:50. J Cell Biol (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling Tech, 9532 S) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 2
In order to investigate the effect of a microtubule inhibitor, MPT0B098, on STAT3 signaling in oral squamous cell carcinoma, Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3f
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 3f). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 5e
In order to examine how Stat5a modulation affects breast cancer cells, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:500 (fig 5e). Mol Cancer Res (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples at 1:1000 (fig 3). Exp Ther Med (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 3). Exp Ther Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 6
In order to study alleviation of impaired mitochondrial biogenesis by twinkle overexpression preventing cardiac rupture after myocardial infarction, Cell Signaling Technology PARP antibody (Cell Signaling, 9544S) was used in western blot on mouse samples (fig 6). Am J Physiol Heart Circ Physiol (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 5c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig 5c). J Transl Med (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3c). Oncotarget (2016) ncbi
mouse monoclonal (19F4)
  • western blot; human; loading ...; fig s1b
Cell Signaling Technology PARP antibody (Cell Signaling, 9546) was used in western blot on human samples (fig s1b). J Mol Med (Berl) (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 7
In order to study protection of mice from high fat diet-induced liver injury by receptor interacting protein 3, Cell Signaling Technology PARP antibody (Cell Signaling, 9544) was used in western blot on mouse samples (fig 7). Hepatology (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 7b
In order to demonstrate that miR-181a inhibits mitophagy, Cell Signaling Technology PARP antibody (Cell signaling, 5625) was used in western blot on human samples (fig 7b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 4
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 6
Cell Signaling Technology PARP antibody (Cell Signaling, 9544) was used in western blot on mouse samples (fig 6). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4
Cell Signaling Technology PARP antibody (CST, 9532) was used in western blot on human samples (fig 4). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 1
  • immunohistochemistry; human; fig 1
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in immunocytochemistry on human samples (fig 1), in immunohistochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • immunocytochemistry; human; fig 1
  • immunohistochemistry; human; fig 1
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in immunocytochemistry on human samples (fig 1), in immunohistochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 1). Int J Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s3b
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig s3b) and in western blot on human samples (fig 2c). Carcinogenesis (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology PARP antibody (Cell Signaling, 9541S) was used in western blot on human samples (fig 3c). Sci Rep (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology PARP antibody (Cell signaling, 9532) was used in western blot on human samples at 1:1000 (fig 1). J Ovarian Res (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 7
In order to study promotion of survival of breast cancer cells in response to hyper-fractionated radiation treatment by RAC1 GTPase, Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 7). Oncogene (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; rat; loading ...; fig 4e
In order to investigate the role of autophagy in the anti-neurotoxicity effect of resveratrol, Cell Signaling Technology PARP antibody (Cell signaling, 9532S) was used in western blot on rat samples (fig 4e). Neurochem Res (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 1b
In order to report that Noxa-mediated MCL-1 phosphorylation and subsequent MCL-1 degradation is critical for DNA damaging agent-induced apoptosis, Cell Signaling Technology PARP antibody (Cell Signaling, D64E10) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3h
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3h). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to determine the promotion of genomic and phenotypic changes in glioblastoma cells by temozolomide, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6). Cancer Cell Int (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 9
Cell Signaling Technology PARP antibody (Cell Signaling Tech, 9542) was used in western blot on human samples at 1:1000 (fig 9). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1). Autophagy (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2). BMC Complement Altern Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 4). Breast Cancer Res Treat (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
In order to study regulation of repair of DNA double-strand breaks in triple-negative breast cancer by long noncoding RNA LINP1, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 1). Nat Struct Mol Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s2
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9541) was used in western blot on human samples (fig s2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology PARP antibody (Cell Signaling Tech, 9541) was used in western blot on human samples (fig 4). Cancer Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 3). Onco Targets Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2b
In order to determine the functional significance of miR-145-3p and bladder cancer oncogenic pathways, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples at 1:500 (fig 2b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:500; loading ...; fig 2b
In order to determine the functional significance of miR-145-3p and bladder cancer oncogenic pathways, Cell Signaling Technology PARP antibody (Cell signaling, 5625) was used in western blot on human samples at 1:500 (fig 2b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 1). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 1
In order to analyze induction of efficient anti-tumor immunity by vaccination with necroptotic cancer cells, Cell Signaling Technology PARP antibody (Cell Signaling, 9544) was used in western blot on mouse samples (fig 1). Cell Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s5
In order to investigate the consequences of genetic or pharmacological inhibition of BMI1, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig s5). Autophagy (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
In order to elucidate inhibition of BCL-W and BCL-XL by directed elimination of senescent cells, Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 5e). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 5e). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2). Int J Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 7a). Oncol Rep (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • immunohistochemistry - paraffin section; human; fig 5
  • western blot; human; fig 5
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in immunohistochemistry - paraffin section on human samples (fig 5) and in western blot on human samples (fig 5). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (46D11)
  • reverse phase protein lysate microarray; mouse; fig s1.b,c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in reverse phase protein lysate microarray on mouse samples (fig s1.b,c). EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; fig 7
Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples at 1:2000 (fig 7). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; fig 7
Cell Signaling Technology PARP antibody (Cell Signaling, 9541S) was used in western blot on human samples at 1:2000 (fig 7). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 2c
In order to elucidate the mechanism of cisplatin-induced non-small-cell lung cancer cell apoptosis, Cell Signaling Technology PARP antibody (Cell Signaling, D64E10) was used in western blot on human samples (fig 2c). Biochem Biophys Res Commun (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; loading ...; fig 5b
In order to study the effects of a HDAC 3-selective inhibitor, RGFP966, on NF-kB and histones, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples at 1:1000 (fig 5b). Biochem Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3d
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 3d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4f
In order to show how FADD regulates NF-kappaB activation and promotes ubiquitination of cFLIPL, which induces apoptosis, Cell Signaling Technology PARP antibody (Cell signaling technology, 9542P) was used in western blot on human samples at 1:1000 (fig 4f). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; fig s5
In order to characterize how mitochondrial Ca(21) uptake through MICU1 regulation dictates tissue regeneration and survival, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples at 1:1000 (fig s5). Nat Commun (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 2
Cell Signaling Technology PARP antibody (Cell Signaling Technolog, 9532) was used in western blot on mouse samples (fig 2). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to investigate the role of CHD5 in renal cell carcinoma, Cell Signaling Technology PARP antibody (Cell Signal, 9541) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6b
Cell Signaling Technology PARP antibody (cell signalling, 9542) was used in western blot on human samples (fig 6b). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
In order to characterize multiple molecularly defined cancer indications by studying ROS1, ALK inhibitor, Entrectinib, a Pan-TRK activity, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples (fig 2). Mol Cancer Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3f
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3f). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (cell Signaling Tech, 9542 S) was used in western blot on human samples (fig 3). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 2d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1a
Cell Signaling Technology PARP antibody (Cell Signaling, 9544) was used in western blot on mouse samples (fig 1a). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to study increased dissociation of hexokinase II from mitochondrial outer membrane by overexpression or ErbB2 rendering breast cancer cells susceptible to 3-BrPA, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 4). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling Tech, 9542S) was used in western blot on human samples (fig 3). Sci Signal (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3
Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples at 1:1000 (fig s3). Int J Biochem Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig s3). Int J Biochem Cell Biol (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; rat; fig 1
In order to determine regulation of global protein synthesis by inactivating eukaryotic translation initiation factor 2-alpha by the small molecule '1-(4-biphenylylcarbonyl)-4-(5-bromo-2-methoxybenzyl) piperazine oxalate' and its derivatives, Cell Signaling Technology PARP antibody (Cell signaling, 9532) was used in western blot on rat samples (fig 1). Cell Stress Chaperones (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4f
In order to study the role of PHF8 during mesodermal and cardiac lineage commitment using mouse embryonic stem cells, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on mouse samples at 1:1000 (fig 4f). Stem Cells (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling Technology, cst-9532) was used in western blot on human samples at 1:1000 (fig 3). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6d
In order to study quinacrine-induced apoptosis, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6d). Biochem Pharmacol (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
In order to investigate proteolytic processing of p27, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:2000 (fig 3). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s8
In order to evaluate the differential responses to H3N2 influenza virus infection in vitro in human nasal epithelial cells derived from multiple subjects, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig s8). J Allergy Clin Immunol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell signaling, 9541) was used in western blot on human samples (fig 1). Mol Cancer (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9541) was used in western blot on human samples (fig 6a). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig s1
In order to analyze delay of neurodegeneration by preventing stress-induced OPA1 processing in mitochondria by loss of OMA1, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on mouse samples (fig s1). J Cell Biol (2016) ncbi
domestic rabbit monoclonal (46D11)
  • immunoprecipitation; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in immunoprecipitation on human samples (fig 3). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology PARP antibody (Cell signalling, 9542) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (7C9)
  • western blot; mouse; 1:1000; fig 7
Cell Signaling Technology PARP antibody (Cell Signaling, 9548) was used in western blot on mouse samples at 1:1000 (fig 7). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • immunocytochemistry; human; 1:1000; fig 4
In order to study regulation of adhesion and cell migration by recruitment to the leading edge by human phosphatase CDC14A, Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in immunocytochemistry on human samples at 1:1000 (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; fig 5
In order to report the role for EPHA2 in the cell survival of tyrosine kinase inhibitors-resistant, EGFR-mutant lung cancers, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples at 1:1000 (fig 5). Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 2c). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; fig s5
In order to investigate the role of FOXO1 in vascular growth, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples at 1:1000 (fig s5). Nature (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig s5
In order to investigate the role of FOXO1 in vascular growth, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig s5). Nature (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 5
Cell Signaling Technology PARP antibody (Cell signaling, 9532) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; mouse; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in immunoprecipitation on mouse samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology PARP antibody (Cell Signalling, 9542) was used in western blot on human samples (fig 5). Oncogene (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 2
In order to investigate role of PRDXs in lymphoma, Cell Signaling Technology PARP antibody (Cell Signalling, 5625) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 6
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples (fig 2d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 7). Nucleic Acids Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 2
In order to report the mechanism by which imiquimod induces apoptosis in melanoma cells, Cell Signaling Technology PARP antibody (Cell Signalling Technology, 9542) was used in western blot on human samples at 1:500 (fig 2). J Cell Mol Med (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3
In order to study the effects of HDAC inhibitors and BCL-2 inhibitors on small cell lung cancer lines, Cell Signaling Technology PARP antibody (Cell Signaling, D64E10) was used in western blot on human samples (fig 3). Cancer Biol Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 2c
In order to evaluate the use of phenformin with MLN0128 as a treatment strategy for non-small cell lung carcinoma, Cell Signaling Technology PARP antibody (Cell signaling, 5625) was used in western blot on human samples at 1:1000 (fig 2c). Cancer Res (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 2i
In order to assess the definition of obligate participation in multiple hallmarks of cancer by a comprehensive functional characterization of cancer-testis antigens, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 2i). Nat Commun (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2d
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 2d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 9e
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 9e). J Virol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 2
In order to characterize inhibition of gamma-irradiation-induced apoptosis of prostate cancer cells by elevated expression of hepatoma up-regulated protein, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:500 (fig 2). J Cell Biochem (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology PARP antibody (cell signalling, 9532) was used in western blot on human samples (fig 3c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 2e
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 2e). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3c). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; rat; fig 2
Cell Signaling Technology PARP antibody (Cell Signaling, 9545) was used in western blot on rat samples (fig 2). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (46D11)
  • other; human; fig 1
  • immunocytochemistry; human; fig 1
In order to study the involvement of TIMELESS in the PARP1-mediated DNA damage response, Cell Signaling Technology PARP antibody (Cell Signalling, 46D11) was used in other on human samples (fig 1) and in immunocytochemistry on human samples (fig 1). Cell Rep (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2f
In order to study the role of ASCT2/SLC1A5 in the regulation of glutamine uptake and tumour growth, Cell Signaling Technology PARP antibody (Cell Signaling, 9541) was used in western blot on human samples (fig 2f). Oncogene (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, 5625S) was used in western blot on human samples (fig 1). Sci Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 5h
In order to study the relationship between arginine methylation and ubiquitylation in carcinogenesis and KLF4-mediated stability, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 5h). Nat Commun (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig s4f
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig s4f). Nature (2015) ncbi
mouse monoclonal (19F4)
  • western blot; human; 1:1000; fig 6c
In order to report that an inhibitor of the bromodomain and extraterminal family of proteins suppresses pancreatic ductal adenocarcinoma, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9546) was used in western blot on human samples at 1:1000 (fig 6c). Nat Med (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:300; fig 6d
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples at 1:300 (fig 6d). FEBS Open Bio (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6b
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6b). Neuroendocrinology (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 5a
Cell Signaling Technology PARP antibody (Cell Signaling, D64E10) was used in western blot on human samples (fig 5a). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9545) was used in western blot on human samples . Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1k
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 1k). Oncogene (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (Cell signaling, 9532) was used in western blot on human samples (fig 3). Leukemia (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling Tech, 9532) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:2000
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples at 1:2000. Mol Oncol (2015) ncbi
mouse monoclonal (7C9)
  • western blot; rat; 1:5000; fig s3
Cell Signaling Technology PARP antibody (Cell Signaling, 9548) was used in western blot on rat samples at 1:5000 (fig s3). Exp Cell Res (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2
Cell Signaling Technology PARP antibody (Cell Signaling Tech, 9532) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 5
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 5). J Biol Chem (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to analyze protection of urothelial cell carcinoma from treatment-induced DNA damage via YAP activation, Cell Signaling Technology PARP antibody (Cell signaling, 9542) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; rat; 1:1000; fig 4
In order to elucidate ketamine-induced ulcerative cystitis and bladder apoptosis in association with oxidative stress mediated by mitochondria and the endoplasmic reticulum, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on rat samples at 1:1000 (fig 4). Am J Physiol Renal Physiol (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; fig 6
In order to study alpha-synuclein tetramers, Cell Signaling Technology PARP antibody (Cell Signaling, D64E10) was used in western blot on human samples at 1:1000 (fig 6). Nat Commun (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2). Sci Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:250; fig 4c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:250 (fig 4c). Oncotarget (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig s3
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig s3). Cell Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig s2a
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig s2a). Sci Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
In order to investigate how RIG-I-like receptors prevent cancer, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 3). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 5625P) was used in western blot on human samples at 1:1000 (fig 3). Cell Death Dis (2015) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 1c
Cell Signaling Technology PARP antibody (Cell Signaling, 9542) was used in western blot on rat samples (fig 1c). Mol Neurobiol (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • immunohistochemistry - paraffin section; human; fig 4
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in immunohistochemistry - paraffin section on human samples (fig 4) and in western blot on human samples (fig 3). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 9c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 9c). Autophagy (2016) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig f4
Cell Signaling Technology PARP antibody (cell signaling technology, 5625S) was used in western blot on human samples (fig f4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 1f, 2a, 4h
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 1f, 2a, 4h). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 8c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples (fig 8c). J Biol Chem (2015) ncbi
mouse monoclonal (19F4)
  • immunohistochemistry; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling Technologies, 19F4) was used in immunohistochemistry on human samples (fig 3). Nature (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples at 1:1000 (fig 5c). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; mouse; 1:1000; loading ...; fig 5c
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on mouse samples at 1:1000 (fig 5c) and in western blot on human samples at 1:1000 (fig 3c). Mol Med Rep (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples . Int J Oncol (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 6
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig 6). PLoS Pathog (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5d
In order to study the role of STAT3 in KRAS mutant lung adenocarcinoma., Cell Signaling Technology PARP antibody (Cell signaling, 9532) was used in western blot on human samples (fig 5d). Nat Commun (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig s4
Cell Signaling Technology PARP antibody (Cell signaling, 9532) was used in western blot on human samples (fig s4). Nat Neurosci (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell Signaling, D65E10) was used in western blot on human samples (fig 1). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell signaling Technology, 5625) was used in western blot on human samples . J Cell Biochem (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 2
Cell Signaling Technology PARP antibody (Cell Signaling, 9532S) was used in western blot on mouse samples (fig 2). DNA Repair (Amst) (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 5a
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 5a). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig s3
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig s3). Cancer Discov (2015) ncbi
mouse monoclonal (19F4)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell signaling, 9546) was used in western blot on human samples . Mol Cancer Ther (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532 s) was used in western blot on human samples at 1:1000. J Exp Clin Cancer Res (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology PARP antibody (Cell signaling, 9532) was used in western blot on human samples (fig 1). J Cereb Blood Flow Metab (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 1A
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 1A). Mol Med Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 6
In order to identify PITX1 as a key specificity factor for HIF-1alpha dependent gene expression, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6). Cell Cycle (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; rat; fig 1f
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on rat samples (fig 1f). J Biol Chem (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000. Cancer Lett (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000. Oncotarget (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig s1
  • western blot; rat; fig 1
In order to elucidate both MTP-dependent and -independent roles of PDI1, Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig s1) and in western blot on rat samples (fig 1). Mol Biol Cell (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
In order to investigate the use of paradox-breaking pan-RAF inhibitors to treat cancer, Cell Signaling Technology PARP antibody (Cell Signaling, D64E10) was used in western blot on human samples . Cancer Cell (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human
In order to investigate the use of paradox-breaking pan-RAF inhibitors to treat cancer, Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples . Cancer Cell (2015) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 3). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4D
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 4D). Oncotarget (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 10e
In order to identify DUBA as a suppressor of IL-17 production in T cells, Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on mouse samples (fig 10e). Nature (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples . Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 5
Cell Signaling Technology PARP antibody (Cell Signaling Technologies, 5625) was used in western blot on human samples (fig 5). J Med Chem (2015) ncbi
domestic rabbit monoclonal (46D11)
  • immunoprecipitation; human; fig 4a
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in immunoprecipitation on human samples (fig 4a). Cell Rep (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples (fig 1c). Oncogene (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples . Gynecol Oncol (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples . J Biol Chem (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
In order to study reprogramming of cells toward a metastatic-like state by p53 psi, a transcriptionally inactive p53 isoform, Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 3). Proc Natl Acad Sci U S A (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
In order to determine the effects of ASP3026treatment on NPM-ALK+ ALCL cell lines in vitro and on systemic lymphoma growth in vivo, Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625S) was used in western blot on human samples . Oncotarget (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 6
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 5625) was used in western blot on human samples (fig 6). J Pathol (2014) ncbi
mouse monoclonal (19F4)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signalling Technology, 19F4) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 6d
Cell Signaling Technology PARP antibody (Cell Signaling, D64E10) was used in western blot on human samples (fig 6d). Oncotarget (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 9532) was used in western blot on human samples . Cell Death Differ (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000
Cell Signaling Technology PARP antibody (Cell Signaling, 46D11) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse
Cell Signaling Technology PARP antibody (Cell Signaling Technology, 46D11) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
In order to evaluate the effect of Noxa on the localization and stability of MCL-1 in small cell lung cancer, Cell Signaling Technology PARP antibody (Cell Signaling Technology, D64E10) was used in western blot on human samples . Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • flow cytometry; human; fig 3
Cell Signaling Technology PARP antibody (Cell Signaling, 8978) was used in flow cytometry on human samples (fig 3). Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling Technology, D64E10) was used in western blot on human samples . Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 6
Cell Signaling Technology PARP antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6). Free Radic Biol Med (2014) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling, 9185) was used in western blot on human samples . Mol Cancer Ther (2014) ncbi
mouse monoclonal (19F4)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling, 9546) was used in western blot on human samples . Cancer Res (2013) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; 1:500
Cell Signaling Technology PARP antibody (Cell Signaling, 5625) was used in western blot on human samples at 1:500. Pathol Oncol Res (2013) ncbi
domestic rabbit monoclonal (D64E10)
  • western blot; human; fig 1c
Cell Signaling Technology PARP antibody (Cell Signalling Technologies, 5625S) was used in western blot on human samples (fig 1c). Br J Cancer (2012) ncbi
mouse monoclonal (19F4)
  • western blot; mouse; fig 6
In order to investigate the role of caspase 8 in acute brain injury in mouse models, Cell Signaling Technology PARP antibody (Cell Signaling, 9546S) was used in western blot on mouse samples (fig 6). PLoS ONE (2011) ncbi
mouse monoclonal (19F4)
  • western blot; human
Cell Signaling Technology PARP antibody (Cell Signaling, 9546) was used in western blot on human samples . Int J Cancer (2011) ncbi
Promega
polyclonal
  • western blot; human; loading ...; fig s3d
Promega PARP antibody (Promega, G7341) was used in western blot on human samples (fig s3d). J Clin Invest (2017) ncbi
polyclonal
  • western blot; human; 1:500; loading ...; fig s6a
Promega PARP antibody (Promega, G734A) was used in western blot on human samples at 1:500 (fig s6a). Nat Cell Biol (2016) ncbi
polyclonal
  • immunohistochemistry; rat; 1:100; fig 6
  • western blot; rat; 1:2000; fig 7
Promega PARP antibody (Promega, G7341) was used in immunohistochemistry on rat samples at 1:100 (fig 6) and in western blot on rat samples at 1:2000 (fig 7). Invest Ophthalmol Vis Sci (2016) ncbi
polyclonal
  • western blot; human; fig 1
Promega PARP antibody (Promega, G7341) was used in western blot on human samples (fig 1). PLoS Genet (2016) ncbi
polyclonal
  • western blot; mouse; fig 6
Promega PARP antibody (Promega Corporation, G7341) was used in western blot on mouse samples (fig 6). Cell Death Differ (2016) ncbi
BD Biosciences
mouse monoclonal (C2-10)
  • western blot; human; loading ...; fig 2d
BD Biosciences PARP antibody (BD Pharmingen, 556362) was used in western blot on human samples (fig 2d). PLoS Pathog (2019) ncbi
mouse monoclonal (C2-10)
  • western blot; human; 1:1000; loading ...; fig 3
BD Biosciences PARP antibody (BD Pharmingen, 556362) was used in western blot on human samples at 1:1000 (fig 3). Sci Rep (2019) ncbi
mouse monoclonal (C2-10)
  • western blot; human; loading ...; fig 3c
BD Biosciences PARP antibody (BD Biosciences, 556362) was used in western blot on human samples (fig 3c). Cell Rep (2018) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; loading ...; fig 6e
BD Biosciences PARP antibody (BD Biosciences, 556494) was used in western blot on human samples (fig 6e). Oncogene (2018) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; loading ...; fig 2a
BD Biosciences PARP antibody (BD Pharmingen, 556494) was used in western blot on human samples (fig 2a). J Clin Invest (2017) ncbi
mouse monoclonal (C2-10)
  • western blot; mouse; loading ...; fig 1c
  • western blot; human; loading ...; fig 1f
BD Biosciences PARP antibody (BD Bioscience, 556362) was used in western blot on mouse samples (fig 1c) and in western blot on human samples (fig 1f). EMBO J (2017) ncbi
mouse monoclonal (C2-10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s5a
BD Biosciences PARP antibody (BD Pharmingen, 556362) was used in immunohistochemistry on mouse samples at 1:500 (fig s5a). Science (2017) ncbi
mouse monoclonal (C2-10)
  • western blot; human; loading ...; fig 1a
In order to demonstrate that sorting nexin 1 and 2 are cleaved by initiator caspases during apoptosis, BD Biosciences PARP antibody (BD Biosciences, 556362) was used in western blot on human samples (fig 1a). Cell Death Discov (2017) ncbi
mouse monoclonal (C2-10)
  • western blot; human; loading ...; fig 1c
BD Biosciences PARP antibody (BD biosciences Pharmingen, 556362) was used in western blot on human samples (fig 1c). Int J Biochem Cell Biol (2017) ncbi
mouse monoclonal (F21-852)
  • flow cytometry; human; 1:200; loading ...; fig 6a
BD Biosciences PARP antibody (BD, 558710) was used in flow cytometry on human samples at 1:200 (fig 6a). Int J Mol Sci (2016) ncbi
mouse monoclonal (C2-10)
  • western blot; human; loading ...; fig 1f
In order to elucidate how p21 is suppressed in embryonic stem cells, BD Biosciences PARP antibody (BD Pharmingen, C2-10) was used in western blot on human samples (fig 1f). Sci Rep (2016) ncbi
mouse monoclonal (F21-852)
  • western blot; human; loading ...
BD Biosciences PARP antibody (BD Biosciences, F21-852) was used in western blot on human samples . Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (42/PARP)
  • western blot; human; loading ...; fig 3c
In order to investigate the contribution of PINK1 and PARKIN to cell death, BD Biosciences PARP antibody (BD Biosciences, 42/PARP) was used in western blot on human samples (fig 3c). J Biol Chem (2016) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; 1:1000; fig st2
In order to study inhibition of growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex by ON 01910.Na, BD Biosciences PARP antibody (BD, 556494) was used in western blot on human samples at 1:1000 (fig st2). Transl Res (2016) ncbi
mouse monoclonal (F21-852)
  • western blot; human; 1:1000; fig 3
BD Biosciences PARP antibody (BD Pharmingen, 552597) was used in western blot on human samples at 1:1000 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (C2-10)
  • western blot; mouse; fig 6
In order to study the synergistic activity of fludarabine and deguelin in chronic lymphocytic leukemia patient cells in the New Zealand Black Murine model, BD Biosciences PARP antibody (BD Biosciences, C2-10) was used in western blot on mouse samples (fig 6). PLoS ONE (2016) ncbi
mouse monoclonal (C2-10)
  • immunocytochemistry; human; 1:500; fig 4c
BD Biosciences PARP antibody (BD Pharmingen, 556362) was used in immunocytochemistry on human samples at 1:500 (fig 4c). Mol Oncol (2016) ncbi
mouse monoclonal (F21-852)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences PARP antibody (BD, F21-852) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (4C10-5)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences PARP antibody (BD, 4C10-5) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (7D3-6)
  • western blot; human; fig 4
BD Biosciences PARP antibody (BD Biosciences, 7D3-6) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; fig 3
BD Biosciences PARP antibody (BD Biosciences, 556494) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (C2-10)
  • western blot; human; fig 5
In order to investigate mechanisms of drug resistance using non-Hodgkin's lymphoma cell lines, BD Biosciences PARP antibody (BD Biosciences, C2-10) was used in western blot on human samples (fig 5). Blood Cancer J (2015) ncbi
mouse monoclonal (F21-852)
  • flow cytometry; human; fig 1
  • flow cytometry; mouse; fig 1
In order to study the relationship between the P2X7 receptor and ATP release after ivermectin treatment, BD Biosciences PARP antibody (BD Biosciences, 558576) was used in flow cytometry on human samples (fig 1) and in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (C2-10)
  • western blot; human; fig 2
BD Biosciences PARP antibody (BD Pharmingen, 556362) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; fig 2
BD Biosciences PARP antibody (BD Biosciences, 556494) was used in western blot on human samples (fig 2). Genetics (2015) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; fig 3
BD Biosciences PARP antibody (BD, 556494) was used in western blot on human samples (fig 3). J Cell Biol (2015) ncbi
mouse monoclonal (7D3-6)
  • western blot; human; fig 9
BD Biosciences PARP antibody (BD Pharmingen, 551025) was used in western blot on human samples (fig 9). BMC Cancer (2015) ncbi
mouse monoclonal (42/PARP)
  • western blot; human
In order to study CaeB-mediated apoptosis, BD Biosciences PARP antibody (BD Bioscience, 611038) was used in western blot on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (F21-852)
  • western blot; human; loading ...; fig 4i
In order to study mechanisms that confer resistance to therapeutic interventions in the insulin-like growth factor receptor pathway, BD Biosciences PARP antibody (BD, 552596) was used in western blot on human samples (fig 4i). Mol Cancer (2015) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; 1:1000
BD Biosciences PARP antibody (BD Pharmingen, 556494) was used in western blot on human samples at 1:1000. Carcinogenesis (2015) ncbi
mouse monoclonal (F21-852)
  • western blot; human; 1:5000; fig 3
BD Biosciences PARP antibody (BD Pharmingen, 552596) was used in western blot on human samples at 1:5000 (fig 3). Eur J Cancer (2015) ncbi
mouse monoclonal (7D3-6)
  • western blot; human; 1:1000
BD Biosciences PARP antibody (BD Biosciences, 551024) was used in western blot on human samples at 1:1000. PLoS ONE (2015) ncbi
mouse monoclonal (7D3-6)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 1
In order to analyze the significance biologically and clinically of PARP1 protein expression in breast cancer, BD Biosciences PARP antibody (BD Pharmingen, 7D3-6) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (F21-852)
  • western blot; human; fig 4
BD Biosciences PARP antibody (BD Pharmingen, 552596) was used in western blot on human samples (fig 4). Br J Cancer (2015) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; 1:1000
In order to assess the yield and purity of four different exosome isolation protocols, BD Biosciences PARP antibody (Becton Dickinson, 556494) was used in western blot on human samples at 1:1000. J Extracell Vesicles (2014) ncbi
mouse monoclonal (4C10-5)
  • western blot; human
In order to study the roles of prostate tumor suppressor NKX3.1 in DNA repair and luminal cell differentiation, BD Biosciences PARP antibody (BD Biosciences, 556494) was used in western blot on human samples . F1000Res (2014) ncbi
mouse monoclonal (4C10-5)
  • western blot; human
BD Biosciences PARP antibody (BD Biosciences, 556494) was used in western blot on human samples . Int J Cancer (2015) ncbi
mouse monoclonal (C2-10)
  • immunocytochemistry; human; fig 2
  • western blot; human
BD Biosciences PARP antibody (BD PharMingen, 556362) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples . Mol Biol Cell (2014) ncbi
mouse monoclonal (4C10-5)
  • western blot; human; 1:1000
BD Biosciences PARP antibody (BD, 556494) was used in western blot on human samples at 1:1000. Front Endocrinol (Lausanne) (2014) ncbi
mouse monoclonal (C2-10)
  • western blot; human
BD Biosciences PARP antibody (BD Biosciences, C2-10) was used in western blot on human samples . Mol Pharmacol (2014) ncbi
mouse monoclonal (42/PARP)
  • western blot; human
BD Biosciences PARP antibody (BD Biosciences, 611038) was used in western blot on human samples . Biol Pharm Bull (2014) ncbi
mouse monoclonal (42/PARP)
  • western blot; human
BD Biosciences PARP antibody (BD, 611038) was used in western blot on human samples . Cell (2014) ncbi
mouse monoclonal (F21-852)
  • western blot; human; fig 3
BD Biosciences PARP antibody (BD Pharmingen, F21-852) was used in western blot on human samples (fig 3). Mol Carcinog (2015) ncbi
mouse monoclonal (F21-852)
  • flow cytometry; human; fig 10d
BD Biosciences PARP antibody (BD Biosciences, 552933) was used in flow cytometry on human samples (fig 10d). PLoS ONE (2011) ncbi
mouse monoclonal (C2-10)
  • western blot; human; fig 5
BD Biosciences PARP antibody (BD Pharmingen, 556362) was used in western blot on human samples (fig 5). Nat Immunol (2011) ncbi
mouse monoclonal (4C10-5)
  • western blot; human
BD Biosciences PARP antibody (BD Bioscience, 4C10-5) was used in western blot on human samples . Neuro Oncol (2011) ncbi
mouse monoclonal (4C10-5)
  • western blot; human
In order to investigate the role of TRF2/RAP1 and DNA-PK at telomeric fusion, BD Biosciences PARP antibody (BD Pharmingen, 4C10-5) was used in western blot on human samples . EMBO J (2010) ncbi
Articles Reviewed
  1. Guo S, Chen Y, Yang Y, Zhang X, Ma L, Xue X, et al. TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress. Cell Death Dis. 2021;12:42 pubmed publisher
  2. Xiong M, Wu M, Dan Peng -, Huang W, Chen Z, Ke H, et al. LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells. Cell Death Dis. 2021;12:24 pubmed publisher
  3. Huang H, Yu X, Han X, Hao J, Zhao J, Bebek G, et al. Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression. Cell Rep. 2021;34:108522 pubmed publisher
  4. Riad A, Gitto S, Lee H, Winters H, Martorano P, Hsieh C, et al. PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response. Molecules. 2020;25: pubmed publisher
  5. Song M, YEKU O, Rafiq S, Purdon T, Dong X, Zhu L, et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11:6298 pubmed publisher
  6. Lomphithak T, Choksi S, Mutirangura A, Tohtong R, Tencomnao T, Usubuchi H, et al. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma. Cell Commun Signal. 2020;18:161 pubmed publisher
  7. Moses N, Zhang M, Wu J, Hu C, Xiang S, Geng X, et al. HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1. Cells. 2020;9: pubmed publisher
  8. Cheng C, Wooten J, Gibbs Z, McGlynn K, Mishra P, Whitehurst A. Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma. elife. 2020;9: pubmed publisher
  9. Tan Y, Sementino E, Liu Z, Cai K, Testa J. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis. Sci Rep. 2020;10:15837 pubmed publisher
  10. He S, Fang X, Xia X, Hou T, Zhang T. Targeting CDK9: A novel biomarker in the treatment of endometrial cancer. Oncol Rep. 2020;44:1929-1938 pubmed publisher
  11. Lim C, Or Y, Ong Z, Chung H, Hayashi H, Shrestha S, et al. Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism. elife. 2020;9: pubmed publisher
  12. Nassar Z, Mah C, Dehairs J, Burvenich I, Irani S, Centenera M, et al. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. elife. 2020;9: pubmed publisher
  13. Gu J, Zhang Y, Wang X, Xiang J, Deng S, Wu D, et al. Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway. BMC Complement Med Ther. 2020;20:214 pubmed publisher
  14. Zhang H, Qi L, Du Y, Huang L, Braun F, Kogiso M, et al. Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma. Cancers (Basel). 2020;12: pubmed publisher
  15. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed publisher
  16. Feng Y, Mischler W, Gurung A, Kavanagh T, Androsov G, Sadow P, et al. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis. Cancer Res. 2020;80:2751-2763 pubmed publisher
  17. Xu W, Wu H, Chen S, Wang X, Tanaka S, Sugiyama K, et al. Cytotoxic effects of vitamins K1, K2 and K3 against human T lymphoblastoid leukemia cells through apoptosis induction and cell cycle arrest. Chem Biol Drug Des. 2020;: pubmed publisher
  18. Wu P, Hong S, Starenki D, Oshima K, Shao H, Gestwicki J, et al. Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Oncogene. 2020;39:4257-4270 pubmed publisher
  19. Han B, Meng X, Wu P, Li Z, Li S, Zhang Y, et al. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma. Theranostics. 2020;10:3351-3365 pubmed publisher
  20. Zhang J, Huang J, Zhang Y, Zhang X, Zhao L, Li C, et al. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. EBioMedicine. 2020;53:102701 pubmed publisher
  21. Gallo S, Spilinga M, Albano R, Ferrauto G, Di Gregorio E, Casanova E, et al. Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro. Br J Pharmacol. 2020;177:3107-3122 pubmed publisher
  22. Reynders M, Matsuura B, Bérouti M, Simoneschi D, Marzio A, Pagano M, et al. PHOTACs enable optical control of protein degradation. Sci Adv. 2020;6:eaay5064 pubmed publisher
  23. Howell M, Green R, Khalil R, Foran E, Quarni W, Nair R, et al. Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis. FASEB Bioadv. 2020;2:90-105 pubmed publisher
  24. Pothuraju R, Rachagani S, Krishn S, Chaudhary S, Nimmakayala R, Siddiqui J, et al. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Mol Cancer. 2020;19:37 pubmed publisher
  25. Wan G, An Y, Tao J, Wang Y, Zhou Q, Yang R, et al. MicroRNA-129-5p alleviates spinal cord injury in mice via suppressing the apoptosis and inflammatory response through HMGB1/TLR4/NF-κB pathway. Biosci Rep. 2020;40: pubmed publisher
  26. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed publisher
  27. McNicoll F, Kühnel A, Biswas U, Hempel K, Whelan G, Eichele G, et al. Meiotic sex chromosome cohesion and autosomal synapsis are supported by Esco2. Life Sci Alliance. 2020;3: pubmed publisher
  28. Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer. 2020;19:28 pubmed publisher
  29. Li K, Zhao S, Long J, Su J, Wu L, Tao J, et al. A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products. Cancer Cell Int. 2020;20:36 pubmed publisher
  30. Jiang L, Xu K, Li J, Zhou X, Xu L, Wu Z, et al. Nesfatin-1 suppresses interleukin-1β-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats. Aging (Albany NY). 2020;12:1760-1777 pubmed publisher
  31. Li T, Li K, Zhang S, Wang Y, Xu Y, Cronin S, et al. Overexpression of apoptosis inducing factor aggravates hypoxic-ischemic brain injury in neonatal mice. Cell Death Dis. 2020;11:77 pubmed publisher
  32. Qiao H, Tan X, Lv D, Xing R, Shu F, Zhong C, et al. Phosphoribosyl pyrophosphate synthetases 2 knockdown inhibits prostate cancer progression by suppressing cell cycle and inducing cell apoptosis. J Cancer. 2020;11:1027-1037 pubmed publisher
  33. Aldaz P, Otaegi Ugartemendia M, Sáenz Antoñanzas A, Garcia Puga M, Moreno Valladares M, Flores J, et al. SOX9 promotes tumor progression through the axis BMI1-p21CIP. Sci Rep. 2020;10:357 pubmed publisher
  34. Liu Q, Borcherding N, Shao P, Maina P, Zhang W, Qi H. Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance. EBioMedicine. 2020;51:102612 pubmed publisher
  35. Xue J, Zhao Y, Aronowitz J, Mai T, Vides A, Qeriqi B, et al. Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition. Nature. 2020;577:421-425 pubmed publisher
  36. Almstedt E, Elgendy R, Hekmati N, Rosén E, Wärn C, Olsen T, et al. Integrative discovery of treatments for high-risk neuroblastoma. Nat Commun. 2020;11:71 pubmed publisher
  37. Ding L, Zhu Q, Zhou F, Tan H, Xu W, Pan C, et al. Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma. PLoS Pathog. 2019;15:e1008174 pubmed publisher
  38. Santos Barriopedro I, Li Y, Bahl S, Seto E. HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1. Genes Cancer. 2019;10:119-133 pubmed publisher
  39. Liu X, Huang J, Xie Y, Zhou Y, Wang R, Lou J. Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties. Med Sci Monit. 2019;25:8905-8912 pubmed publisher
  40. Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores Garcia L, Jacobs J, et al. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029-1034 pubmed publisher
  41. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher
  42. Yukawa M, Jagannathan S, Vallabh S, Kartashov A, Chen X, Weirauch M, et al. AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation. J Exp Med. 2020;217: pubmed publisher
  43. Jung J, Lee H, Cao B, Liao P, Zeng S, Lu H. RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53. Oncogene. 2019;: pubmed publisher
  44. Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, et al. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Nat Commun. 2019;10:3882 pubmed publisher
  45. Thangaraj K, Balasubramanian B, Park S, Natesan K, Liu W, Manju V. Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells. Biomolecules. 2019;9: pubmed publisher
  46. Han Y, Wang Z, Sun S, Zhang Z, Liu J, Jin X, et al. Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer. Epigenetics. 2019;:1-12 pubmed publisher
  47. Debruyne D, Dries R, Sengupta S, Seruggia D, Gao Y, Sharma B, et al. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells. Nature. 2019;572:676-680 pubmed publisher
  48. Basturk O, Weigelt B, Adsay V, Benhamida J, Askan G, Wang L, et al. Sclerosing epithelioid mesenchymal neoplasm of the pancreas - a proposed new entity. Mod Pathol. 2020;33:456-467 pubmed publisher
  49. Joyce M, Berry Wynne K, Dos Santos T, Addison W, McFarlane N, Hobman T, et al. HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response. PLoS Pathog. 2019;15:e1007949 pubmed publisher
  50. Guan J, Zhou W, Hafner M, Blake R, Chalouni C, Chen I, et al. Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility. Cell. 2019;178:949-963.e18 pubmed publisher
  51. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed publisher
  52. Sin Chan P, Mumal I, Suwal T, Ho B, Fan X, Singh I, et al. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor. Cancer Cell. 2019;36:51-67.e7 pubmed publisher
  53. Tacconi E, Badie S, De Gregoriis G, Reisländer T, Lai X, Porru M, et al. Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance. EMBO Mol Med. 2019;11:e9982 pubmed publisher
  54. Kaur S, Nag A, Gangenahalli G, Sharma K. Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis. Front Genet. 2019;10:554 pubmed publisher
  55. Wang R, Geng J, Sheng W, Liu X, Jiang M, Zhen Y. The ionophore antibiotic gramicidin A inhibits pancreatic cancer stem cells associated with CD47 down-regulation. Cancer Cell Int. 2019;19:145 pubmed publisher
  56. Pietila M, Sahgal P, Peuhu E, Jäntti N, Paatero I, Närvä E, et al. SORLA regulates endosomal trafficking and oncogenic fitness of HER2. Nat Commun. 2019;10:2340 pubmed publisher
  57. Das R, Schwintzer L, Vinopal S, Roca E, Sylvester M, Oprişoreanu A, et al. New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. J Cell Sci. 2019;: pubmed publisher
  58. Tepper S, Mortusewicz O, Członka E, Bello A, Schmidt A, Jeschke J, et al. Restriction of AID activity and somatic hypermutation by PARP-1. Nucleic Acids Res. 2019;47:7418-7429 pubmed publisher
  59. Fang D, Wang H, Li M, Wei W. α-bisabolol enhances radiotherapy-induced apoptosis in endometrial cancer cells by reducing the effect of XIAP on inhibiting caspase-3. Biosci Rep. 2019;39: pubmed publisher
  60. Bentz G, Lowrey A, Horne D, Nguyen V, Satterfield A, Ross T, et al. Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency. PLoS ONE. 2019;14:e0217578 pubmed publisher
  61. Frischknecht L, Britschgi C, Galliker P, Christinat Y, Vichalkovski A, Gstaiger M, et al. BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly. Sci Rep. 2019;9:7779 pubmed publisher
  62. Wu K, Zou J, Lin C, Jie Z. MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling. Biosci Rep. 2019;: pubmed publisher
  63. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed publisher
  64. Liu X, Zhao P, Wang X, Wang L, Zhu Y, Song Y, et al. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res. 2019;38:184 pubmed publisher
  65. Hernández Alvarez M, Sebastian D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P, et al. Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. Cell. 2019;177:881-895.e17 pubmed publisher
  66. Shi K, Yin X, Cai M, Yan Y, Jia C, Ma P, et al. PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors. elife. 2019;8: pubmed publisher
  67. Chung H, Zou X, Bajar B, Brand V, Huo Y, Alcudia J, et al. A compact synthetic pathway rewires cancer signaling to therapeutic effector release. Science. 2019;364: pubmed publisher
  68. Song T, Spillmann D. Transcriptomic analysis reveals cell apoptotic signature modified by heparanase in melanoma cells. J Cell Mol Med. 2019;23:4559-4568 pubmed publisher
  69. Singh R, Peng S, Viswanath P, Sambandam V, Shen L, Rao X, et al. Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis. EMBO Mol Med. 2019;: pubmed publisher
  70. Xu D, Li X, Shao F, Lv G, Lv H, Lee J, et al. The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62. Sci Adv. 2019;5:eaav4570 pubmed publisher
  71. He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  72. Zheng J, Croteau D, Bohr V, Akbari M. Diminished OPA1 expression and impaired mitochondrial morphology and homeostasis in Aprataxin-deficient cells. Nucleic Acids Res. 2019;: pubmed publisher
  73. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed publisher
  74. Chen M, Du Y, Sun L, Hsu J, Wang Y, Gao Y, et al. H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism. J Biol Chem. 2019;294:8516-8528 pubmed publisher
  75. Luo H, Jing B, Xia Y, Zhang Y, Hu M, Cai H, et al. WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia. Cancer Cell Int. 2019;19:56 pubmed publisher
  76. Gennaro V, Wedegaertner H, McMahon S. Interaction between the BAG1S isoform and HSP70 mediates the stability of anti-apoptotic proteins and the survival of osteosarcoma cells expressing oncogenic MYC. BMC Cancer. 2019;19:258 pubmed publisher
  77. Liu Z, Mar K, Hanners N, Perelman S, Kanchwala M, Xing C, et al. A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB. Nature. 2019;: pubmed publisher
  78. Poondla N, Chandrasekaran A, Heese K, Kim K, Ramakrishna S. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis. Biochem Biophys Res Commun. 2019;: pubmed publisher
  79. Park H, Chung K, An H, Gim J, Hong J, Woo H, et al. Parkin Promotes Mitophagic Cell Death in Adult Hippocampal Neural Stem Cells Following Insulin Withdrawal. Front Mol Neurosci. 2019;12:46 pubmed publisher
  80. Fang G, Qi J, Huang L, Zhao X. LncRNA MRAK048635_P1 is critical for vascular smooth muscle cell function and phenotypic switching in essential hypertension. Biosci Rep. 2019;: pubmed publisher
  81. Yan M, Wang J, Ren Y, Li L, He W, Zhang Y, et al. Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. Cell Death Dis. 2019;10:204 pubmed publisher
  82. Greer Y, Gilbert S, Gril B, Narwal R, Peacock Brooks D, Tice D, et al. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Res. 2019;21:27 pubmed publisher
  83. Yambire K, Fernández Mosquera L, Steinfeld R, Mühle C, Ikonen E, Milosevic I, et al. Mitochondrial biogenesis is transcriptionally repressed in lysosomal lipid storage diseases. elife. 2019;8: pubmed publisher
  84. Dufour F, Silina L, Neyret Kahn H, Moreno Vega A, Krucker C, Karboul N, et al. TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer. Br J Cancer. 2019;120:555-564 pubmed publisher
  85. Frank T, Tuppi M, Hugle M, Dötsch V, van Wijk S, Fulda S. Cell cycle arrest in mitosis promotes interferon-induced necroptosis. Cell Death Differ. 2019;: pubmed publisher
  86. Guan H, Li N, Wang X, Shan X, Li Z, Lin Z. Role of Paip1 on angiogenesis and invasion in pancreatic cancer. Exp Cell Res. 2019;376:198-209 pubmed publisher
  87. Göbel A, Breining D, Rauner M, Hofbauer L, Rachner T. Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells. Cell Death Dis. 2019;10:91 pubmed publisher
  88. Nassour J, Radford R, Correia A, Fusté J, Schoell B, Jauch A, et al. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature. 2019;565:659-663 pubmed publisher
  89. Yuan Z, Zhang H, Hasnat M, Ding J, Chen X, Liang P, et al. A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation. Toxicology. 2019;414:45-56 pubmed publisher
  90. Park B, Chang S, Lee G, Kang B, Kim J, Park H. Wnt3a disrupts GR-TEAD4-PPARγ2 positive circuits and cytoskeletal rearrangement in a β-catenin-dependent manner during early adipogenesis. Cell Death Dis. 2019;10:16 pubmed publisher
  91. Chen L, Yang G, Dong H. Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway. Med Sci Monit. 2019;25:77-86 pubmed publisher
  92. Zhao Z, Wang L, Volk A, Birch N, Stoltz K, Bartom E, et al. Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia. Genes Dev. 2019;33:61-74 pubmed publisher
  93. Xie Y, Fan H, Lu W, Yang Q, Nurkesh A, Yeleussizov T, et al. Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer. Oncogene. 2019;38:2967-2983 pubmed publisher
  94. LeBlanc L, Lee B, Yu A, Kim M, Kambhampati A, Dupont S, et al. Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation. elife. 2018;7: pubmed publisher
  95. Pan W, Moroishi T, Koo J, Guan K. Cell type-dependent function of LATS1/2 in cancer cell growth. Oncogene. 2019;38:2595-2610 pubmed publisher
  96. Wu R, Li A, Sun B, Sun J, Zhang J, Zhang T, et al. A novel m6A reader Prrc2a controls oligodendroglial specification and myelination. Cell Res. 2019;29:23-41 pubmed publisher
  97. Jeon Y, Kim T, Park D, Nuovo G, Rhee S, Joshi P, et al. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC. Nat Commun. 2018;9:5110 pubmed publisher
  98. Unni A, Harbourne B, Oh M, Wild S, Ferrarone J, Lockwood W, et al. Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells. elife. 2018;7: pubmed publisher
  99. Barreta A, Sarian L, Ferracini A, Costa L, Mazzola P, de Angelo Andrade L, et al. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis. Hum Pathol. 2019;85:72-81 pubmed publisher
  100. Liang C, Ma Y, Yong L, Yang C, Wang P, Liu X, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci. 2019;110:166-179 pubmed publisher
  101. Sarracino A, Gharu L, Kula A, Pasternak A, Avettand Fenoel V, Rouzioux C, et al. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. MBio. 2018;9: pubmed publisher
  102. Serebryannyy L, Misteli T. HiPLA: High-throughput imaging proximity ligation assay. Methods. 2019;157:80-87 pubmed publisher
  103. Asnaghi L, White D, Key N, Choi J, Mahale A, Alkatan H, et al. ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma. Oncogene. 2019;38:2056-2075 pubmed publisher
  104. Lafita Navarro M, Kim M, Borenstein Auerbach N, Venkateswaran N, Hao Y, Ray R, et al. The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells. Genes Dev. 2018;32:1303-1308 pubmed publisher
  105. Gallot Y, Bohnert K, Straughn A, Xiong G, Hindi S, Kumar A. PERK regulates skeletal muscle mass and contractile function in adult mice. FASEB J. 2019;33:1946-1962 pubmed publisher
  106. Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181-1192 pubmed publisher
  107. Killackey S, Rahman M, Soares F, Zhang A, Abdel Nour M, Philpott D, et al. The mitochondrial Nod-like receptor NLRX1 modifies apoptosis through SARM1. Mol Cell Biochem. 2019;453:187-196 pubmed publisher
  108. Lee E, Ouzounova M, Piranlioglu R, Ma M, Guzel M, Marasco D, et al. The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20. Oncogene. 2019;38:469-482 pubmed publisher
  109. Greenhough A, Bagley C, Heesom K, Gurevich D, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10: pubmed publisher
  110. Jena K, Kolapalli S, Mehto S, Nath P, Das B, Sahoo P, et al. TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy. EMBO J. 2018;37: pubmed publisher
  111. Slyskova J, Sabatella M, Ribeiro Silva C, Stok C, Theil A, Vermeulen W, et al. Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage. Nucleic Acids Res. 2018;46:9537-9549 pubmed publisher
  112. Tay L, Krishnan V, Sankar H, Chong Y, Chuang L, Tan T, et al. RUNX Poly(ADP-Ribosyl)ation and BLM Interaction Facilitate the Fanconi Anemia Pathway of DNA Repair. Cell Rep. 2018;24:1747-1755 pubmed publisher
  113. Zhao D, Kim Y, Jeong S, Greenson J, Chaudhry M, Hoepting M, et al. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018;128:4970-4979 pubmed publisher
  114. Lai C, Liu H, Tin K, Huang Y, Yeh K, Peng H, et al. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells. Oncogene. 2019;38:317-331 pubmed publisher
  115. Leslie P, Franklin D, Liu Y, Zhang Y. p53 Regulates the Expression of LRP1 and Apoptosis through a Stress Intensity-Dependent MicroRNA Feedback Loop. Cell Rep. 2018;24:1484-1495 pubmed publisher
  116. Zhang J, Wu T, Simon J, Takada M, Saito R, Fan C, et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science. 2018;361:290-295 pubmed publisher
  117. Lin X, Cui M, Xu D, Hong D, Xia Y, Xu C, et al. Liver-specific deletion of Eva1a/Tmem166 aggravates acute liver injury by impairing autophagy. Cell Death Dis. 2018;9:768 pubmed publisher
  118. Johnson D, Taabazuing C, Okondo M, Chui A, Rao S, Brown F, et al. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018;24:1151-1156 pubmed publisher
  119. Wang W, Xia Z, Farre J, Subramani S. TRIM37 deficiency induces autophagy through deregulating the MTORC1-TFEB axis. Autophagy. 2018;14:1574-1585 pubmed publisher
  120. Chhipa R, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, et al. AMP kinase promotes glioblastoma bioenergetics and tumour growth. Nat Cell Biol. 2018;20:823-835 pubmed publisher
  121. Lau A, Chung H, Komada T, Platnich J, Sandall C, Choudhury S, et al. Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury. J Clin Invest. 2018;128:2894-2913 pubmed publisher
  122. Roders N, Herr F, Ambroise G, Thaunat O, Portier A, Vazquez A, et al. SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. Front Immunol. 2018;9:787 pubmed publisher
  123. Zhang X, Zhuang R, Wu H, Chen J, Wang F, Li G, et al. A novel role of endocan in alleviating LPS-induced acute lung injury. Life Sci. 2018;202:89-97 pubmed publisher
  124. Wang S, Liu A, Wu G, Ding H, Huang S, Nahman S, et al. The CPLANE protein Intu protects kidneys from ischemia-reperfusion injury by targeting STAT1 for degradation. Nat Commun. 2018;9:1234 pubmed publisher
  125. Lee C, Hsieh T. Wuho/WDR4 deficiency inhibits cell proliferation and induces apoptosis via DNA damage in mouse embryonic fibroblasts. Cell Signal. 2018;47:16-26 pubmed publisher
  126. Qiang L, Wang J, Zhang Y, Ge P, Chai Q, Li B, et al. Mycobacterium tuberculosis Mce2E suppresses the macrophage innate immune response and promotes epithelial cell proliferation. Cell Mol Immunol. 2018;: pubmed publisher
  127. Lino Cardenas C, Kessinger C, Cheng Y, MacDonald C, Macgillivray T, Ghoshhajra B, et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018;9:1009 pubmed publisher
  128. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed publisher
  129. Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359:920-926 pubmed publisher
  130. Fu X, Zhang C, Meng H, Zhang K, Shi L, Cao C, et al. Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress. Cell Death Differ. 2018;25:1625-1637 pubmed publisher
  131. Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau D, Zavala E, et al. NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci U S A. 2018;115:E1876-E1885 pubmed publisher
  132. Yin R, Guo L, Gu J, Li C, Zhang W. Over expressing miR-19b-1 suppress breast cancer growth by inhibiting tumor microenvironment induced angiogenesis. Int J Biochem Cell Biol. 2018;97:43-51 pubmed publisher
  133. Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed publisher
  134. Chung H, Calis J, Wu X, Sun T, Yu Y, Sarbanes S, et al. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Cell. 2018;172:811-824.e14 pubmed publisher
  135. Janes M, Zhang J, Li L, Hansen R, Peters U, Guo X, et al. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 2018;172:578-589.e17 pubmed publisher
  136. Viswanath P, Radoul M, Izquierdo Garcia J, Ong W, Luchman H, Cairncross J, et al. 2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas. Cancer Res. 2018;78:2290-2304 pubmed publisher
  137. Tan X, Banerjee P, Liu X, Yu J, Gibbons D, Wu P, et al. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. J Clin Invest. 2018;128:1267-1282 pubmed publisher
  138. Margalef P, Kotsantis P, Borel V, Bellelli R, Panier S, Boulton S. Stabilization of Reversed Replication Forks by Telomerase Drives Telomere Catastrophe. Cell. 2018;172:439-453.e14 pubmed publisher
  139. Cao B, Luo L, Feng L, Ma S, Chen T, Ren Y, et al. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer. BMC Cancer. 2017;17:844 pubmed publisher
  140. Cho M, Lee J, Shin M, Kim H, Choi Y, Rho S, et al. TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer. Oncotarget. 2017;8:97990-98003 pubmed publisher
  141. Kline C, Ralff M, Lulla A, Wagner J, Abbosh P, Dicker D, et al. Role of Dopamine Receptors in the Anticancer Activity of ONC201. Neoplasia. 2018;20:80-91 pubmed publisher
  142. Kim M, Morales L, Baek M, Slaga T, DiGiovanni J, Kim D. UVB-induced nuclear translocation of TC-PTP by AKT/14-3-3? axis inhibits keratinocyte survival and proliferation. Oncotarget. 2017;8:90674-90692 pubmed publisher
  143. Shuang W, Hou L, Zhu Y, Li Q, Hu W. Mcl-1 stabilization confers resistance to taxol in human gastric cancer. Oncotarget. 2017;8:82981-82990 pubmed publisher
  144. Tracz Gaszewska Z, Klimczak M, Biecek P, Herok M, Kosiński M, Olszewski M, et al. Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation. Oncotarget. 2017;8:82123-82143 pubmed publisher
  145. Sorokina I, Denisenko T, Imreh G, Tyurin Kuzmin P, Kaminskyy V, Gogvadze V, et al. Involvement of autophagy in the outcome of mitotic catastrophe. Sci Rep. 2017;7:14571 pubmed publisher
  146. Sagulenko V, Vitak N, Vajjhala P, Vince J, Stacey K. Caspase-1 Is an Apical Caspase Leading to Caspase-3 Cleavage in the AIM2 Inflammasome Response, Independent of Caspase-8. J Mol Biol. 2018;430:238-247 pubmed publisher
  147. Thaler S, Schmidt M, Roβwag S, Thiede G, Schad A, Sleeman J. Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells. Oncotarget. 2017;8:72281-72301 pubmed publisher
  148. Paculova H, Kramara J, Simečková S, Fedr R, Soucek K, Hylse O, et al. BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors. Tumour Biol. 2017;39:1010428317727479 pubmed publisher
  149. Miles M, Hawkins C. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. Cell Death Dis. 2017;8:e3062 pubmed publisher
  150. Zhao Z, Jia Q, Wu M, Xie X, Wang Y, Song G, et al. Degalactotigonin, a Natural Compound from Solanum nigrum L., Inhibits Growth and Metastasis of Osteosarcoma through GSK3β Inactivation-Mediated Repression of the Hedgehog/Gli1 Pathway. Clin Cancer Res. 2018;24:130-144 pubmed publisher
  151. Zhang F, Virshup D, Cheong J. Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis. Oncogene. 2018;37:363-376 pubmed publisher
  152. Xu Y, Wang Y, Yao A, Xu Z, Dou H, Shen S, et al. Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway. Sci Rep. 2017;7:11776 pubmed publisher
  153. Jiang X, Bao Y, Liu H, Kou X, Zhang Z, Sun F, et al. VPS34 stimulation of p62 phosphorylation for cancer progression. Oncogene. 2017;36:6850-6862 pubmed publisher
  154. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  155. Chong I, Aronson L, Bryant H, Gulati A, Campbell J, Elliott R, et al. Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018;67:1780-1792 pubmed publisher
  156. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed publisher
  157. Zhou Y, Huang T, Zhang J, Wong C, Zhang B, Dong Y, et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36:6518-6530 pubmed publisher
  158. Takaki T, Montagner M, Serres M, Le Berre M, Russell M, Collinson L, et al. Actomyosin drives cancer cell nuclear dysmorphia and threatens genome stability. Nat Commun. 2017;8:16013 pubmed publisher
  159. Wang W, Xia Z, Farré J, Subramani S. TRIM37, a novel E3 ligase for PEX5-mediated peroxisomal matrix protein import. J Cell Biol. 2017;216:2843-2858 pubmed publisher
  160. Xu L, Zhang M, Li H, Guan W, Liu B, Liu F, et al. SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia. Leuk Lymphoma. 2018;59:918-930 pubmed publisher
  161. Van T, Polykratis A, Straub B, Kondylis V, Papadopoulou N, Pasparakis M. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis. J Clin Invest. 2017;127:2662-2677 pubmed publisher
  162. Xu P, Tao X, Zhao C, Huang Q, Chang H, Ban N, et al. DTX3L is upregulated in glioma and is associated with glioma progression. Int J Mol Med. 2017;40:491-498 pubmed publisher
  163. Kuchay S, Giorgi C, Simoneschi D, Pagan J, Missiroli S, Saraf A, et al. PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth. Nature. 2017;546:554-558 pubmed publisher
  164. Shaffer S, Dunagin M, Torborg S, Torre E, Emert B, Krepler C, et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 2017;546:431-435 pubmed publisher
  165. Sinha S, Thomas D, Chan S, Gao Y, Brunen D, Torabi D, et al. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data. Nat Commun. 2017;8:15580 pubmed publisher
  166. Sykora P, Kanno S, Akbari M, Kulikowicz T, Baptiste B, Leandro G, et al. DNA Polymerase Beta Participates in Mitochondrial DNA Repair. Mol Cell Biol. 2017;37: pubmed publisher
  167. Kim J, Hu Z, Cai L, Li K, Choi E, Faubert B, et al. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. Nature. 2017;546:168-172 pubmed publisher
  168. Ramírez Peinado S, Ignashkova T, van Raam B, Baumann J, Sennott E, Gendarme M, et al. TRAPPC13 modulates autophagy and the response to Golgi stress. J Cell Sci. 2017;130:2251-2265 pubmed publisher
  169. Jung J, Kim L, Wang X, Wu Q, Sanvoranart T, Hubert C, et al. Nicotinamide metabolism regulates glioblastoma stem cell maintenance. JCI Insight. 2017;2: pubmed publisher
  170. Shin C, Lee M, Han J, Jeong S, Ryu B, Chi S. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017;114:5683-5688 pubmed publisher
  171. White M, Lin C, Rajapakshe K, Dong J, Shi Y, Tsouko E, et al. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer. Mol Cancer Res. 2017;15:1017-1028 pubmed publisher
  172. Sangodkar J, Perl A, Tohme R, Kiselar J, Kastrinsky D, Zaware N, et al. Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth. J Clin Invest. 2017;127:2081-2090 pubmed publisher
  173. Nayar U, Sadek J, Reichel J, Hernandez Hopkins D, Akar G, Barelli P, et al. Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies. J Clin Invest. 2017;127:2066-2080 pubmed publisher
  174. Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H, et al. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. Cancer Cell. 2017;31:685-696.e6 pubmed publisher
  175. Yue X, Zuo Y, Ke H, Luo J, Lou L, Qin W, et al. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Biochem Pharmacol. 2017;137:29-50 pubmed publisher
  176. Liu Y, Chen X, Li J. Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress. Mol Med Rep. 2017;15:2457-2464 pubmed publisher
  177. Vivo M, Fontana R, Ranieri M, Capasso G, Angrisano T, Pollice A, et al. p14ARF interacts with the focal adhesion kinase and protects cells from anoikis. Oncogene. 2017;36:4913-4928 pubmed publisher
  178. Kitazawa S, Ebara S, Ando A, Baba Y, Satomi Y, Soga T, et al. Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors. Oncotarget. 2017;8:28922-28938 pubmed publisher
  179. Zhao H, Zhang L, Zhang Y, Zhao L, Wan Q, Wang B, et al. Calmodulin promotes matrix metalloproteinase 9 production and cell migration by inhibiting the ubiquitination and degradation of TBC1D3 oncoprotein in human breast cancer cells. Oncotarget. 2017;8:36383-36398 pubmed publisher
  180. Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, et al. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017;36:4778-4789 pubmed publisher
  181. He M, Tan B, Vasan K, Yuan H, Cheng F, Ramos da Silva S, et al. SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells. J Pathol. 2017;242:309-321 pubmed publisher
  182. Xiao Z, Gaertner S, Morresi Hauf A, Genzel R, Duell T, Ullrich A, et al. Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients. Neoplasia. 2017;19:385-395 pubmed publisher
  183. Zhang X, Fan J, Wang S, Li Y, Wang Y, Li S, et al. Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non-Small Cell Lung Cancer. Cancer Immunol Res. 2017;5:363-375 pubmed publisher
  184. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed publisher
  185. Mehta N, Lyon J, Patil K, Mokarram N, Kim C, Bellamkonda R. Bacterial Carriers for Glioblastoma Therapy. Mol Ther Oncolytics. 2017;4:1-17 pubmed publisher
  186. Bhattacharya S, Srinivasan K, Abdisalaam S, Su F, Raj P, Dozmorov I, et al. RAD51 interconnects between DNA replication, DNA repair and immunity. Nucleic Acids Res. 2017;45:4590-4605 pubmed publisher
  187. Xiong G, Hindi S, Mann A, Gallot Y, Bohnert K, Cavener D, et al. The PERK arm of the unfolded protein response regulates satellite cell-mediated skeletal muscle regeneration. elife. 2017;6: pubmed publisher
  188. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  189. Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7:44735 pubmed publisher
  190. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  191. Coni S, Mancuso A, Di Magno L, Sdruscia G, Manni S, Serrao S, et al. Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Sci Rep. 2017;7:44079 pubmed publisher
  192. Cho H, Um J, Lee J, Kim W, Kang W, Kim S, et al. ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes. Sci Rep. 2017;7:44186 pubmed publisher
  193. Li K, Mo C, Gong D, Chen Y, Huang Z, Li Y, et al. DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin. Cancer Lett. 2017;400:194-202 pubmed publisher
  194. Lafont E, Kantari Mimoun C, Dráber P, De Miguel D, Hartwig T, Reichert M, et al. The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death. EMBO J. 2017;36:1147-1166 pubmed publisher
  195. Kong P, Zhu X, Geng Q, Xia L, Sun X, Chen Y, et al. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer. Mol Ther. 2017;25:1027-1037 pubmed publisher
  196. Voráčová K, Hajek J, Mares J, Urajová P, Kuzma M, Cheel J, et al. The cyanobacterial metabolite nocuolin a is a natural oxadiazine that triggers apoptosis in human cancer cells. PLoS ONE. 2017;12:e0172850 pubmed publisher
  197. Iurlaro R, Püschel F, León Annicchiarico C, O Connor H, Martin S, Palou Gramón D, et al. Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors. Mol Cell Biol. 2017;37: pubmed publisher
  198. Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O Neil N, et al. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours. Nat Commun. 2017;8:14432 pubmed publisher
  199. Williams P, Harder J, Foxworth N, Cochran K, Philip V, Porciatti V, et al. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355:756-760 pubmed publisher
  200. Toots M, Männik A, Mumm K, Tämm K, Tamm T, Ustav E, et al. Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay. PLoS Pathog. 2017;13:e1006168 pubmed publisher
  201. Duclos C, Champagne A, Carrier J, Saucier C, Lavoie C, Denault J. Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling. Cell Death Discov. 2017;3:16100 pubmed publisher
  202. Li G, Ji T, Chen J, Fu Y, Hou L, Feng Y, et al. CRL4DCAF8 Ubiquitin Ligase Targets Histone H3K79 and Promotes H3K9 Methylation in the Liver. Cell Rep. 2017;18:1499-1511 pubmed publisher
  203. Yang H, Ju F, Guo X, Ma S, Wang L, Cheng B, et al. RNA-binding protein RBM3 prevents NO-induced apoptosis in human neuroblastoma cells by modulating p38 signaling and miR-143. Sci Rep. 2017;7:41738 pubmed publisher
  204. Pergola C, Schubert K, Pace S, Ziereisen J, Nikels F, Scherer O, et al. Modulation of actin dynamics as potential macrophage subtype-targeting anti-tumour strategy. Sci Rep. 2017;7:41434 pubmed publisher
  205. Liu J, Wang Y, Song L, Zeng L, Yi W, Liu T, et al. A critical role of DDRGK1 in endoplasmic reticulum homoeostasis via regulation of IRE1α stability. Nat Commun. 2017;8:14186 pubmed publisher
  206. Cabukusta B, Kol M, Kneller L, Hilderink A, Bickert A, Mina J, et al. ER residency of the ceramide phosphoethanolamine synthase SMSr relies on homotypic oligomerization mediated by its SAM domain. Sci Rep. 2017;7:41290 pubmed publisher
  207. Villar V, Nguyen T, Delcroix V, Terés S, Bouchecareilh M, Salin B, et al. mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nat Commun. 2017;8:14124 pubmed publisher
  208. Xu S, Yang Z, Fan Y, Guan B, Jia J, Gao Y, et al. Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53. Oncol Lett. 2016;12:4999-5006 pubmed publisher
  209. Chang V, Tsai Y, Tsai Y, Peng S, Chen S, Chang T, et al. Krüpple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene. Radiother Oncol. 2017;122:476-484 pubmed publisher
  210. Tagal V, Wei S, Zhang W, Brekken R, Posner B, Peyton M, et al. SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers. Nat Commun. 2017;8:14098 pubmed publisher
  211. Aksoy P, Meneses P. The Role of DCT in HPV16 Infection of HaCaTs. PLoS ONE. 2017;12:e0170158 pubmed publisher
  212. Sizdahkhani S, Feldman M, Piazza M, Ksendzovsky A, Edwards N, Ray Chaudhury A, et al. Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target. Sci Rep. 2017;7:40822 pubmed publisher
  213. Granato M, Rizzello C, Gilardini Montani M, Cuomo L, Vitillo M, Santarelli R, et al. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways. J Nutr Biochem. 2017;41:124-136 pubmed publisher
  214. Scott N, Rogers L, Prudova A, Brown N, Fortelny N, Overall C, et al. Interactome disassembly during apoptosis occurs independent of caspase cleavage. Mol Syst Biol. 2017;13:906 pubmed publisher
  215. Herold N, Rudd S, Ljungblad L, Sanjiv K, Myrberg I, Paulin C, et al. Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies. Nat Med. 2017;23:256-263 pubmed publisher
  216. Li G, Fu R, Shen H, Zhou J, Hu X, Liu Y, et al. Polyphyllin I induces mitophagic and apoptotic cell death in human breast cancer cells by increasing mitochondrial PINK1 levels. Oncotarget. 2017;8:10359-10374 pubmed publisher
  217. Brasacchio D, Alsop A, Noori T, Lufti M, Iyer S, Simpson K, et al. Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization. Cell Death Differ. 2017;24:961-970 pubmed publisher
  218. Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535 pubmed publisher
  219. Jostes S, Nettersheim D, Fellermeyer M, Schneider S, Hafezi F, Honecker F, et al. The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo. J Cell Mol Med. 2017;21:1300-1314 pubmed publisher
  220. Chao T, Zhou X, Cao B, Liao P, Liu H, Chen Y, et al. Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. Nat Commun. 2016;7:13755 pubmed publisher
  221. Sha J, Xue W, Dong B, Pan J, Wu X, Li D, et al. PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer. Oncotarget. 2017;8:6114-6129 pubmed publisher
  222. Damas N, Marcatti M, Come C, Christensen L, Nielsen M, Baumgartner R, et al. SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization. Nat Commun. 2016;7:13875 pubmed publisher
  223. Hoch N, Hanzlikova H, Rulten S, Tetreault M, Komulainen E, Ju L, et al. XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature. 2017;541:87-91 pubmed publisher
  224. Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan X, et al. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017;8:9251-9266 pubmed publisher
  225. Dawar S, Lim Y, Puccini J, White M, Thomas P, Bouchier Hayes L, et al. Caspase-2-mediated cell death is required for deleting aneuploid cells. Oncogene. 2017;36:2704-2714 pubmed publisher
  226. Wang F, Jia J, Lal N, Zhang D, Chiu A, Wan A, et al. High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature. Cardiovasc Res. 2016;112:656-668 pubmed
  227. Hanzlikova H, Gittens W, Krejcikova K, Zeng Z, Caldecott K. Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin. Nucleic Acids Res. 2017;45:2546-2557 pubmed publisher
  228. Nuzzo A, Giuffrida D, Masturzo B, Mele P, Piccoli E, Eva C, et al. Altered expression of G1/S phase cell cycle regulators in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise. Cell Cycle. 2017;16:200-212 pubmed publisher
  229. Chhabra A, Mukherji B, Batra D. Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53. Expert Opin Ther Targets. 2017;21:117-129 pubmed publisher
  230. Seo B, Min K, Woo S, Choe M, Choi K, Lee Y, et al. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP. Antioxid Redox Signal. 2017;27:215-233 pubmed publisher
  231. Park S, Jwa E, Shin S, Ju E, Park I, Pak J, et al. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage. Int J Biochem Cell Biol. 2017;83:47-55 pubmed publisher
  232. Ishikawa Y, Gamo K, Yabuki M, Takagi S, Toyoshima K, Nakayama K, et al. A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells. Mol Cancer Ther. 2017;16:273-284 pubmed publisher
  233. McKenzie C, D Avino P. Investigating cytokinesis failure as a strategy in cancer therapy. Oncotarget. 2016;7:87323-87341 pubmed publisher
  234. Morishita M, Kawamoto T, Hara H, Onishi Y, Ueha T, Minoda M, et al. AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway. Int J Oncol. 2017;50:23-30 pubmed publisher
  235. Godfrey L, Kerry J, Thorne R, Repapi E, Davies J, Tapia M, et al. MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation. Exp Hematol. 2017;47:64-75 pubmed publisher
  236. Martínez Castillo M, Bonilla Moreno R, Alemán Lazarini L, Meraz Rios M, Orozco L, Cedillo Barron L, et al. A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe. PLoS ONE. 2016;11:e0165971 pubmed publisher
  237. Park J, Lee C, Kim H, Kim D, Son J, Ko E, et al. Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling. Oncotarget. 2016;7:83308-83318 pubmed publisher
  238. Huang Z, Her L. The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity. Mol Neurobiol. 2017;54:7382-7400 pubmed publisher
  239. Liu X, Lu D, Bowser R, Liu J. Expression of Carbonic Anhydrase I in Motor Neurons and Alterations in ALS. Int J Mol Sci. 2016;17: pubmed
  240. Schlierf A, Altmann E, Quancard J, Jefferson A, Assenberg R, Renatus M, et al. Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat Commun. 2016;7:13166 pubmed publisher
  241. Dey K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, et al. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. Cancer Gene Ther. 2016;23:382-391 pubmed publisher
  242. Fang Y, Kong Y, Xi J, Zhu M, Zhu T, Jiang T, et al. Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity. Oncotarget. 2016;7:79327-79341 pubmed publisher
  243. Zhao X, Li L, Wang X, Fu R, Lv Y, Jin W, et al. Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0164752 pubmed publisher
  244. Shao X, Lai D, Zhang L, Xu H. Induction of Autophagy and Apoptosis via PI3K/AKT/TOR Pathways by Azadirachtin A in Spodoptera litura Cells. Sci Rep. 2016;6:35482 pubmed publisher
  245. Qi D, Cobrinik D. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene. 2017;36:1760-1769 pubmed publisher
  246. Choi Y, Shembade N, Parvatiyar K, Balachandran S, Harhaj E. TAX1BP1 Restrains Virus-Induced Apoptosis by Facilitating Itch-Mediated Degradation of the Mitochondrial Adaptor MAVS. Mol Cell Biol. 2017;37: pubmed publisher
  247. Alexander Savino C, Hayden M, Richardson C, Zhao J, Poligone B. Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells. Oncotarget. 2016;7:75954-75967 pubmed publisher
  248. Guan S, Zhao Y, Lu J, Yu Y, Sun W, Mao X, et al. Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis. Oncotarget. 2016;7:75914-75925 pubmed publisher
  249. Zhao Y, Fan D, Ru B, Cheng K, Hu S, Zhang J, et al. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells. Eur J Cancer. 2016;68:38-50 pubmed publisher
  250. Figueroa González G, García Castillo V, Coronel Hernández J, López Urrutia E, León Cabrera S, Arias Romero L, et al. Anti-inflammatory and Antitumor Activity of a Triple Therapy for a Colitis-Related Colorectal Cancer. J Cancer. 2016;7:1632-1644 pubmed
  251. Chaabane W, Appell M. Interconnections between apoptotic and autophagic pathways during thiopurine-induced toxicity in cancer cells: the role of reactive oxygen species. Oncotarget. 2016;7:75616-75634 pubmed publisher
  252. Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, et al. Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress. Sci Rep. 2016;6:34330 pubmed publisher
  253. Wei R, Lin S, Wu W, Chen L, Li C, Chen H, et al. A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells. Toxicol Appl Pharmacol. 2016;311:88-98 pubmed publisher
  254. Joo D, Tang Y, Blonska M, Jin J, Zhao X, Lin X. Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of RNF31. Mol Cell Biol. 2016;36:3010-3018 pubmed
  255. Asnaghi L, Tripathy A, Yang Q, Kaur H, Hanaford A, Yu W, et al. Targeting Notch signaling as a novel therapy for retinoblastoma. Oncotarget. 2016;7:70028-70044 pubmed publisher
  256. Ghorai A, Sarma A, Chowdhury P, Ghosh U. PARP-1 depletion in combination with carbon ion exposure significantly reduces MMPs activity and overall increases TIMPs expression in cultured HeLa cells. Radiat Oncol. 2016;11:126 pubmed
  257. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  258. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  259. Krepler C, Xiao M, Samanta M, Vultur A, Chen H, Brafford P, et al. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget. 2016;7:71211-71222 pubmed publisher
  260. Shi Y, Yu Y, Wang Z, Wang H, Bieerkehazhi S, Zhao Y, et al. Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells. Oncotarget. 2016;7:73697-73710 pubmed publisher
  261. Bahr J, Robey R, Luchenko V, Basseville A, Chakraborty A, Kozlowski H, et al. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016;7:69804-69815 pubmed publisher
  262. Zhang Q, Jin R, Zhang X, Sheng J, Yu F, Tan R, et al. The putative oncotarget CSN5 controls a transcription-uncorrelated p53-mediated autophagy implicated in cancer cell survival under curcumin treatment. Oncotarget. 2016;7:69688-69702 pubmed publisher
  263. Carbonneau M, M Gagné L, Lalonde M, Germain M, Motorina A, Guiot M, et al. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat Commun. 2016;7:12700 pubmed publisher
  264. Ranjan K, Pathak C. Expression of FADD and cFLIPL balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death. Mol Cell Biochem. 2016;422:135-150 pubmed
  265. Tavana O, Li D, Dai C, Lopez G, Banerjee D, Kon N, et al. HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat Med. 2016;22:1180-1186 pubmed publisher
  266. Liu T, Xiong J, Yi S, Zhang H, Zhou S, Gu L, et al. FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2. Oncogene. 2017;36:1678-1686 pubmed publisher
  267. Klingbeil O, Lesche R, Gelato K, Haendler B, Lejeune P. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis. 2016;7:e2365 pubmed publisher
  268. Olianas M, Dedoni S, Onali P. LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells. J Pharmacol Exp Ther. 2016;359:340-353 pubmed
  269. Heulot M, Chevalier N, Puyal J, Margue C, Michel S, Kreis S, et al. The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner. Oncotarget. 2016;7:64342-64359 pubmed publisher
  270. Lee J, Jung H, Han Y, Yoon Y, Yun C, Sun H, et al. Antioxidant effects of Cirsium setidens extract on oxidative stress in human mesenchymal stem cells. Mol Med Rep. 2016;14:3777-84 pubmed publisher
  271. Edinger N, Lebendiker M, Klein S, Zigler M, Langut Y, Levitzki A. Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF. PLoS ONE. 2016;11:e0162321 pubmed publisher
  272. Twardziok M, Kleinsimon S, Rolff J, Jäger S, Eggert A, Seifert G, et al. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma. PLoS ONE. 2016;11:e0159749 pubmed publisher
  273. Jiao Z, Wu J, Liu C, Wen B, Zhao W, Du X. Nicotinic ?7 receptor inhibits the acylation stimulating protein?induced production of monocyte chemoattractant protein?1 and keratinocyte?derived chemokine in adipocytes by modulating the p38 kinase and nuclear factor??B signaling pathways. Mol Med Rep. 2016;14:2959-66 pubmed publisher
  274. Waters A, Stafman L, Garner E, Mruthyunjayappa S, Stewart J, Mroczek Musulman E, et al. Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells. Transl Oncol. 2016;9:263-73 pubmed publisher
  275. Cunningham C, Li S, Vizeacoumar F, Bhanumathy K, Lee J, Parameswaran S, et al. Therapeutic relevance of the protein phosphatase 2A in cancer. Oncotarget. 2016;7:61544-61561 pubmed publisher
  276. Oza J, Ganguly B, Kulkarni A, Ginjala V, Yao M, Ganesan S. A Novel Role of Chromodomain Protein CBX8 in DNA Damage Response. J Biol Chem. 2016;291:22881-22893 pubmed
  277. Nakazawa S, Oikawa D, Ishii R, Ayaki T, Takahashi H, Takeda H, et al. Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis. Nat Commun. 2016;7:12547 pubmed publisher
  278. Nagano T, Nakano M, Nakashima A, Onishi K, Yamao S, Enari M, et al. Identification of cellular senescence-specific genes by comparative transcriptomics. Sci Rep. 2016;6:31758 pubmed publisher
  279. Pomares H, Palmeri C, Iglesias Serret D, Moncunill Massaguer C, Saura Esteller J, Núñez Vázquez S, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016;7:64987-65000 pubmed publisher
  280. Timucin A, Basaga H. SIRT6 Is a Positive Regulator of Aldose Reductase Expression in U937 and HeLa cells under Osmotic Stress: In Vitro and In Silico Insights. PLoS ONE. 2016;11:e0161494 pubmed publisher
  281. Cao L, Zhang L, Zhao X, Zhang Y. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0161025 pubmed publisher
  282. Kang M, Park K, Yang J, Lee C, Oh S, Yun J, et al. miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells. PLoS ONE. 2016;11:e0160961 pubmed publisher
  283. Duan H, Lee J, Moon S, Arora D, Li Y, Lim H, et al. Discovery, Synthesis, and Evaluation of 2,4-Diaminoquinazolines as a Novel Class of Pancreatic ?-Cell-Protective Agents against Endoplasmic Reticulum (ER) Stress. J Med Chem. 2016;59:7783-800 pubmed publisher
  284. Ronaghan N, Shang J, Iablokov V, Zaheer R, Colarusso P, Dion S, et al. The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction. Am J Physiol Gastrointest Liver Physiol. 2016;311:G466-79 pubmed publisher
  285. El Jamal S, Taylor E, Abd Elmageed Z, Alamodi A, Selimovic D, Alkhateeb A, et al. Interferon gamma-induced apoptosis of head and neck squamous cell carcinoma is connected to indoleamine-2,3-dioxygenase via mitochondrial and ER stress-associated pathways. Cell Div. 2016;11:11 pubmed publisher
  286. Busada J, Velte E, Serra N, Cook K, Niedenberger B, Willis W, et al. Rhox13 is required for a quantitatively normal first wave of spermatogenesis in mice. Reproduction. 2016;152:379-88 pubmed publisher
  287. Liu H, Li W, Yu X, Gao F, Duan Z, Ma X, et al. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. 2016;7:56338-56354 pubmed publisher
  288. Anta B, Pérez Rodríguez A, Castro J, García Domínguez C, Ibiza S, Martínez N, et al. PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes. Cell Death Dis. 2016;7:e2311 pubmed publisher
  289. Liu M, Feng L, Sun P, Liu W, Wu W, Jiang B, et al. A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice. PLoS ONE. 2016;11:e0159789 pubmed publisher
  290. Rada M, Vasileva E, Lezina L, Marouco D, Antonov A, Macip S, et al. Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene. 2017;36:922-932 pubmed publisher
  291. Wu J, Lei H, Zhang J, Chen X, Tang C, Wang W, et al. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation. Oncotarget. 2016;7:58995-59005 pubmed publisher
  292. Grinshtein N, Rioseco C, Marcellus R, UEHLING D, Aman A, Lun X, et al. Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells. Oncotarget. 2016;7:59360-59376 pubmed publisher
  293. Cheng Y, Huang C, Lee Y, Tien L, Ku W, Chien R, et al. Knocking down of heat-shock protein 27 directs differentiation of functional glutamatergic neurons from placenta-derived multipotent cells. Sci Rep. 2016;6:30314 pubmed publisher
  294. Williams A, Mehler V, Mueller C, Vonhoff F, White R, Duch C. Apoptotic Activity of MeCP2 Is Enhanced by C-Terminal Truncating Mutations. PLoS ONE. 2016;11:e0159632 pubmed publisher
  295. Saisana M, Griffin S, May F. Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation. Oncotarget. 2016;7:54445-54462 pubmed publisher
  296. Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, et al. Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma. Onco Targets Ther. 2016;9:3925-37 pubmed publisher
  297. Jin H, Won M, Park S, Lee S, Park M, Bae J. FOXL2 Is an Essential Activator of SF-1-Induced Transcriptional Regulation of Anti-Müllerian Hormone in Human Granulosa Cells. PLoS ONE. 2016;11:e0159112 pubmed publisher
  298. Hogg S, Newbold A, Vervoort S, Cluse L, Martin B, Gregory G, et al. BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members. Mol Cancer Ther. 2016;15:2030-41 pubmed publisher
  299. Jacobsen R, Mazloumi Gavgani F, Mellgren G, Lewis A. DNA Topoisomerase II? contributes to the early steps of adipogenesis in 3T3-L1 cells. Cell Signal. 2016;28:1593-603 pubmed publisher
  300. Cantú A, Altshuler Keylin S, Laird D. Discrete somatic niches coordinate proliferation and migration of primordial germ cells via Wnt signaling. J Cell Biol. 2016;214:215-29 pubmed publisher
  301. Chen Z, Wang Z, Pang J, Yu Y, Bieerkehazhi S, Lu J, et al. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Sci Rep. 2016;6:29090 pubmed publisher
  302. Peng H, Cheng Y, Hsu Y, Wu G, Kuo C, Liou J, et al. MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma. PLoS ONE. 2016;11:e0158440 pubmed publisher
  303. Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, et al. Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy. Onco Targets Ther. 2016;9:3501-9 pubmed publisher
  304. Heckler M, Zeleke T, Divekar S, Fernandez A, Tiek D, Woodrick J, et al. Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer. Oncotarget. 2016;7:47201-47220 pubmed publisher
  305. Medler T, Craig J, Fiorillo A, Feeney Y, Harrell J, Clevenger C. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth. Mol Cancer Res. 2016;14:994-1008 pubmed
  306. Walerych D, Lisek K, Sommaggio R, Piazza S, Ciani Y, Dalla E, et al. Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. Nat Cell Biol. 2016;18:897-909 pubmed publisher
  307. Li Q, Guo Y, Chen F, Liu J, Jin P. Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing. Exp Ther Med. 2016;12:45-50 pubmed
  308. Itahana Y, Zhang J, Göke J, Vardy L, Han R, Iwamoto K, et al. Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells. Sci Rep. 2016;6:28112 pubmed publisher
  309. Inoue T, Ikeda M, Ide T, Fujino T, Matsuo Y, Arai S, et al. Twinkle overexpression prevents cardiac rupture after myocardial infarction by alleviating impaired mitochondrial biogenesis. Am J Physiol Heart Circ Physiol. 2016;311:H509-19 pubmed publisher
  310. Shen J, Li Z, Li L, Lu L, Xiao Z, Wu W, et al. Vascular-targeted TNF? and IFN? inhibits orthotopic colorectal tumor growth. J Transl Med. 2016;14:187 pubmed publisher
  311. Ono H, Basson M, Ito H. P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer. Oncotarget. 2016;7:51301-51310 pubmed publisher
  312. Nasri I, Bonnet D, Zwarycz B, d Aldebert E, Khou S, Mezghani Jarraya R, et al. PAR2-dependent activation of GSK3? regulates the survival of colon stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol. 2016;311:G221-36 pubmed publisher
  313. Esmaeili M, Pungsrinont T, Schaefer A, Baniahmad A. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling. J Mol Med (Berl). 2016;94:1167-1179 pubmed
  314. Akabane S, Matsuzaki K, Yamashita S, Arai K, Okatsu K, Kanki T, et al. Constitutive Activation of PINK1 Protein Leads to Proteasome-mediated and Non-apoptotic Cell Death Independently of Mitochondrial Autophagy. J Biol Chem. 2016;291:16162-74 pubmed publisher
  315. Roychowdhury S, McCullough R, Sanz Garcia C, Saikia P, Alkhouri N, Matloob A, et al. Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury. Hepatology. 2016;64:1518-1533 pubmed publisher
  316. Hey F, Giblett S, Forrest S, Herbert C, Pritchard C. Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3α/β Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine. PLoS ONE. 2016;11:e0156877 pubmed publisher
  317. Cheng M, Liu L, Lao Y, Liao W, Liao M, Luo X, et al. MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis. Oncotarget. 2016;7:42274-42287 pubmed publisher
  318. Raina K, Lu J, Qian Y, Altieri M, Gordon D, Rossi A, et al. PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2016;113:7124-9 pubmed publisher
  319. Tejada T, Tan L, Torres R, Calvert J, Lambert J, Zaidi M, et al. IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction. Proc Natl Acad Sci U S A. 2016;113:6949-54 pubmed publisher
  320. Liu Z, Lam N, Wang E, Virden R, Pawel B, Attiyeh E, et al. Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma. Oncogene. 2017;36:97-109 pubmed publisher
  321. Andersen A, Flinck M, Oernbo E, Pedersen N, Viuff B, Pedersen S. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment. Mol Cancer. 2016;15:45 pubmed publisher
  322. Gilmore J, Sardiu M, Groppe B, Thornton J, Liu X, Dayebgadoh G, et al. WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. PLoS ONE. 2016;11:e0155492 pubmed publisher
  323. Huang Y, Yang X, Xu T, Kong Q, Zhang Y, Shen Y, et al. Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs. Int J Oncol. 2016;49:153-63 pubmed publisher
  324. Sun F, Zhang Z, Tan E, Lim Z, Li Y, Wang X, et al. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice. Carcinogenesis. 2016;37:701-711 pubmed publisher
  325. Yalon M, Tuval Kochen L, Castel D, Moshe I, Mazal I, Cohen O, et al. Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations. PLoS ONE. 2016;11:e0155711 pubmed publisher
  326. Ranjan A, Srivastava S. Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis. Sci Rep. 2016;6:26165 pubmed publisher
  327. Ribeiro J, Schorl C, Yano N, Romano N, Kim K, Singh R, et al. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells. J Ovarian Res. 2016;9:28 pubmed publisher
  328. Hein A, Post C, Sheinin Y, Lakshmanan I, Natarajan A, Enke C, et al. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene. 2016;35:6319-6329 pubmed publisher
  329. Deng H, Mi M. Resveratrol Attenuates A?25-35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling Pathway. Neurochem Res. 2016;41:2367-79 pubmed publisher
  330. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  331. Nakajima W, Sharma K, Lee J, Maxim N, Hicks M, Vu T, et al. DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex. Oncotarget. 2016;7:36353-36365 pubmed publisher
  332. Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, et al. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Oncotarget. 2016;7:34785-99 pubmed publisher
  333. Xue H, Yuan G, Guo X, Liu Q, Zhang J, Gao X, et al. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway. Autophagy. 2016;12:1129-52 pubmed publisher
  334. Stepanenko A, Andreieva S, Korets K, Mykytenko D, Baklaushev V, Huleyuk N, et al. Temozolomide promotes genomic and phenotypic changes in glioblastoma cells. Cancer Cell Int. 2016;16:36 pubmed publisher
  335. Dai Y, Hung L, Chen R, Lai C, Chang K. ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex. Transl Res. 2016;175:129-143.e13 pubmed publisher
  336. O Santos A, Parrini M, Camonis J. RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases. PLoS ONE. 2016;11:e0154840 pubmed publisher
  337. Rosiak K, Smolarz M, Stec W, Peciak J, Grzela D, Winiecka Klimek M, et al. IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis. PLoS ONE. 2016;11:e0154726 pubmed publisher
  338. Watanabe Y, Papoutsoglou P, Maturi V, Tsubakihara Y, Hottiger M, Heldin C, et al. Regulation of Bone Morphogenetic Protein Signaling by ADP-ribosylation. J Biol Chem. 2016;291:12706-23 pubmed publisher
  339. Strappazzon F, Di Rita A, Cianfanelli V, D Orazio M, Nazio F, Fimia G, et al. Prosurvival AMBRA1 turns into a proapoptotic BH3-like protein during mitochondrial apoptosis. Autophagy. 2016;12:963-75 pubmed publisher
  340. Choi H, Kim M, Choi Y, Shin Y, Cho S, Ko S. Rhus verniciflua Stokes (RVS) and butein induce apoptosis of paclitaxel-resistant SKOV-3/PAX ovarian cancer cells through inhibition of AKT phosphorylation. BMC Complement Altern Med. 2016;16:122 pubmed publisher
  341. Du R, Liu Z, Hou X, Fu G, An N, Wang L. Trichostatin A potentiates genistein-induced apoptosis and reverses EMT in HEp2 cells. Mol Med Rep. 2016;13:5045-52 pubmed publisher
  342. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  343. Zhang Y, He Q, Hu Z, Feng Y, Fan L, Tang Z, et al. Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer. Nat Struct Mol Biol. 2016;23:522-30 pubmed publisher
  344. Song J, Wang Y, Teng M, Zhang S, Yin M, Lu J, et al. Cordyceps militaris induces tumor cell death via the caspase?dependent mitochondrial pathway in HepG2 and MCF?7 cells. Mol Med Rep. 2016;13:5132-40 pubmed publisher
  345. Rebolleda N, Losada Fernandez I, Perez Chacon G, Castejon R, Rosado S, Morado M, et al. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model. PLoS ONE. 2016;11:e0154159 pubmed publisher
  346. Chowdhury B, Porter E, Stewart J, Ferreira C, Schipma M, Dykhuizen E. PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma. PLoS ONE. 2016;11:e0153718 pubmed publisher
  347. Choh V, Gurdita A, Tan B, Prasad R, Bizheva K, Joos K. Short-Term Moderately Elevated Intraocular Pressure Is Associated With Elevated Scotopic Electroretinogram Responses. Invest Ophthalmol Vis Sci. 2016;57:2140-51 pubmed publisher
  348. Itsumi M, Shiota M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, et al. Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2. Cancer Sci. 2016;107:1022-8 pubmed publisher
  349. Zeng W, Liu Q, Chen Z, Wu X, Zhong Y, Wu J. Silencing of hERG1 Gene Inhibits Proliferation and Invasion, and Induces Apoptosis in Human Osteosarcoma Cells by Targeting the NF-?B Pathway. J Cancer. 2016;7:746-57 pubmed publisher
  350. Jeong J, Noh M, Choi J, Lee H, Kim S. Neuroprotective and antioxidant activities of bamboo salt soy sauce against H2O2-induced oxidative stress in rat cortical neurons. Exp Ther Med. 2016;11:1201-1210 pubmed
  351. Xiao L, Shi X, Zhang Y, Zhu Y, Zhu L, Tian W, et al. YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells. Onco Targets Ther. 2016;9:1105-14 pubmed publisher
  352. Matsushita R, Yoshino H, Enokida H, Goto Y, Miyamoto K, Yonemori M, et al. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness. Oncotarget. 2016;7:28460-87 pubmed publisher
  353. Hall A, Lu W, Godfrey J, Antonov A, Paicu C, Moxon S, et al. The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration. Cell Death Dis. 2016;7:e2184 pubmed publisher
  354. Aaes T, Kaczmarek A, Delvaeye T, De Craene B, De Koker S, Heyndrickx L, et al. Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. Cell Rep. 2016;15:274-87 pubmed publisher
  355. Dey A, Mustafi S, Saha S, Kumar Dhar Dwivedi S, Mukherjee P, Bhattacharya R. Inhibition of BMI1 induces autophagy-mediated necroptosis. Autophagy. 2016;12:659-70 pubmed publisher
  356. Yosef R, Pilpel N, Tokarsky Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7:11190 pubmed publisher
  357. Kwon S, Grisan V, Jang B, Herbert J, Badenhorst P. Genome-Wide Mapping Targets of the Metazoan Chromatin Remodeling Factor NURF Reveals Nucleosome Remodeling at Enhancers, Core Promoters and Gene Insulators. PLoS Genet. 2016;12:e1005969 pubmed publisher
  358. Slørdahl T, Abdollahi P, Vandsemb E, Rampa C, Misund K, Baranowska K, et al. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells. Oncotarget. 2016;7:27295-306 pubmed publisher
  359. Li C, Jung S, Yang Y, Kim K, Lim J, Cheon C, et al. Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines. Int J Oncol. 2016;48:2639-46 pubmed publisher
  360. Sumiyoshi H, Matsushita A, Nakamura Y, Matsuda Y, Ishiwata T, Naito Z, et al. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. Oncol Rep. 2016;35:3216-26 pubmed publisher
  361. Lian Y, Yuan J, Cui Q, Feng Q, Xu M, Bei J, et al. Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma. PLoS ONE. 2016;11:e0152820 pubmed publisher
  362. Garcia C, Videla Richardson G, Dimopoulos N, Fernandez Espinosa D, Miriuka S, Sevlever G, et al. Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199. PLoS ONE. 2016;11:e0152607 pubmed publisher
  363. Viringipurampeer I, Metcalfe A, Bashar A, Sivak O, Yanai A, Mohammadi Z, et al. NLRP3 inflammasome activation drives bystander cone photoreceptor cell death in a P23H rhodopsin model of retinal degeneration. Hum Mol Genet. 2016;25:1501-16 pubmed publisher
  364. Gruosso T, Mieulet V, Cardon M, Bourachot B, Kieffer Y, Devun F, et al. Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO Mol Med. 2016;8:527-49 pubmed publisher
  365. Liu X, Xiao Z, Han L, Zhang J, Lee S, Wang W, et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat Cell Biol. 2016;18:431-42 pubmed publisher
  366. Matsumoto M, Nakajima W, Seike M, Gemma A, Tanaka N. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Biochem Biophys Res Commun. 2016;473:490-6 pubmed publisher
  367. Leus N, van der Wouden P, van den Bosch T, Hooghiemstra W, Ourailidou M, Kistemaker L, et al. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Biochem Pharmacol. 2016;108:58-74 pubmed publisher
  368. Lee J, Kim H, Rho S, Lee S. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells. Oncotarget. 2016;7:18541-57 pubmed publisher
  369. Ranjan K, Pathak C. FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Sci Rep. 2016;6:22787 pubmed publisher
  370. Atiq R, Hertz R, Eldad S, Smeir E, Bar Tana J. Suppression of B-Raf(V600E) cancers by MAPK hyper-activation. Oncotarget. 2016;7:18694-704 pubmed publisher
  371. Antony A, Paillard M, Moffat C, Juskeviciute E, Correnti J, Bolon B, et al. MICU1 regulation of mitochondrial Ca(2+) uptake dictates survival and tissue regeneration. Nat Commun. 2016;7:10955 pubmed publisher
  372. Myers S, Peddada S, Chatterjee N, Friedrich T, Tomoda K, Krings G, et al. SOX2 O-GlcNAcylation alters its protein-protein interactions and genomic occupancy to modulate gene expression in pluripotent cells. elife. 2016;5:e10647 pubmed publisher
  373. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed publisher
  374. Du Z, Li L, Huang X, Jin J, Huang S, Zhang Q, et al. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation. Oncotarget. 2016;7:21618-30 pubmed publisher
  375. Rai R, Chen Y, Lei M, Chang S. TRF2-RAP1 is required to protect telomeres from engaging in homologous recombination-mediated deletions and fusions. Nat Commun. 2016;7:10881 pubmed publisher
  376. Kemp M, Sancar A. ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress. J Biol Chem. 2016;291:9330-42 pubmed publisher
  377. Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, et al. Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications. Mol Cancer Ther. 2016;15:628-39 pubmed publisher
  378. Singh A, Joshi S, Zulcic M, Alcaraz M, GARLICH J, Morales G, et al. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma. PLoS ONE. 2016;11:e0150836 pubmed publisher
  379. Shin M, He Y, Marrogi E, Piperdi S, Ren L, Khanna C, et al. A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells. PLoS Genet. 2016;12:e1005884 pubmed publisher
  380. Tepper S, Jeschke J, Böttcher K, Schmidt A, Davari K, Müller P, et al. PARP activation promotes nuclear AID accumulation in lymphoma cells. Oncotarget. 2016;7:13197-208 pubmed publisher
  381. Nakayama R, Zhang Y, Czaplinski J, Anatone A, Sicinska E, Fletcher J, et al. Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma. Oncotarget. 2016;7:16581-92 pubmed publisher
  382. Colangelo T, Polcaro G, Ziccardi P, Muccillo L, Galgani M, Pucci B, et al. The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells. Cell Death Dis. 2016;7:e2108 pubmed publisher
  383. Gari H, Gearheart C, Fosmire S, Degala G, Fan Z, Torkko K, et al. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers. Oncotarget. 2016;7:15757-71 pubmed publisher
  384. Yufune S, Satoh Y, Akai R, Yoshinaga Y, Kobayashi Y, Endo S, et al. Suppression of ERK phosphorylation through oxidative stress is involved in the mechanism underlying sevoflurane-induced toxicity in the developing brain. Sci Rep. 2016;6:21859 pubmed publisher
  385. Gao S, Chen X, Jin H, Ren S, Liu Z, Fang X, et al. Overexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase II from mitochondrial outer membrane. Oncol Lett. 2016;11:1567-1573 pubmed
  386. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed publisher
  387. Zhang W, Shi H, Zhang M, Liu B, Mao S, Li L, et al. Poly C binding protein 1 represses autophagy through downregulation of LC3B to promote tumor cell apoptosis in starvation. Int J Biochem Cell Biol. 2016;73:127-136 pubmed publisher
  388. Hung M, Chen Y, Chu P, Shih C, Yu H, Tai W, et al. Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential. Oncogene. 2016;35:4891-902 pubmed publisher
  389. Hong M, Nam K, Kim K, Kim S, Kim I. The small molecule '1-(4-biphenylylcarbonyl)-4-(5-bromo-2-methoxybenzyl) piperazine oxalate' and its derivatives regulate global protein synthesis by inactivating eukaryotic translation initiation factor 2-alpha. Cell Stress Chaperones. 2016;21:485-97 pubmed publisher
  390. Pesakhov S, Nachliely M, Barvish Z, Aqaqe N, Schwartzman B, Voronov E, et al. Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid. Oncotarget. 2016;7:31847-61 pubmed publisher
  391. Kim N, Kim M, Sung P, Bae Y, Shin E, Yoo J. Interferon-inducible protein SCOTIN interferes with HCV replication through the autolysosomal degradation of NS5A. Nat Commun. 2016;7:10631 pubmed publisher
  392. Tang Y, Hong Y, Bai H, Wu Q, Chen C, Lang J, et al. Plant Homeo Domain Finger Protein 8 Regulates Mesodermal and Cardiac Differentiation of Embryonic Stem Cells Through Mediating the Histone Demethylation of pmaip1. Stem Cells. 2016;34:1527-40 pubmed publisher
  393. Ding M, Bruick R, Yu Y. Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling. Nat Cell Biol. 2016;18:319-27 pubmed publisher
  394. Preet R, Siddharth S, Satapathy S, Das S, Nayak A, Das D, et al. Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Biochem Pharmacol. 2016;105:23-33 pubmed publisher
  395. Lopez J, Bessou M, Riley J, Giampazolias E, Todt F, Rochegüe T, et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat Commun. 2016;7:10538 pubmed publisher
  396. Ware M, Colbert K, Keshishian V, Ho J, Corr S, Curley S, et al. Generation of Homogenous Three-Dimensional Pancreatic Cancer Cell Spheroids Using an Improved Hanging Drop Technique. Tissue Eng Part C Methods. 2016;22:312-21 pubmed publisher
  397. Podmirseg S, Jäkel H, Ranches G, Kullmann M, Sohm B, Villunger A, et al. Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion. Oncogene. 2016;35:4580-90 pubmed publisher
  398. Soriano A, París Coderch L, Jubierre L, Martínez A, Zhou X, Piskareva O, et al. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes. Oncotarget. 2016;7:9271-87 pubmed publisher
  399. Yan Y, Tan K, Li C, Tran T, Chao S, Sugrue R, et al. Human nasal epithelial cells derived from multiple subjects exhibit differential responses to H3N2 influenza virus infection in vitro. J Allergy Clin Immunol. 2016;138:276-281.e15 pubmed publisher
  400. Koyani C, Kitz K, Rossmann C, Bernhart E, Huber E, Trummer C, et al. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death. Biochem Pharmacol. 2016;104:29-41 pubmed publisher
  401. Luey B, May F. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway. Mol Cancer. 2016;15:8 pubmed publisher
  402. Rasmussen R, Gajjar M, Jensen K, Hamerlik P. Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma. Mol Oncol. 2016;10:751-63 pubmed publisher
  403. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed publisher
  404. Moriwaki K, Chan F. Regulation of RIPK3- and RHIM-dependent Necroptosis by the Proteasome. J Biol Chem. 2016;291:5948-59 pubmed publisher
  405. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  406. Korwitz A, Merkwirth C, Richter Dennerlein R, Tröder S, Sprenger H, Quirós P, et al. Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria. J Cell Biol. 2016;212:157-66 pubmed publisher
  407. Du Y, Yamaguchi H, Wei Y, Hsu J, Wang H, Hsu Y, et al. Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors. Nat Med. 2016;22:194-201 pubmed publisher
  408. Cousin F, Jouan Lanhouet S, Théret N, Brenner C, Jouan E, Le Moigne Muller G, et al. The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer. Oncotarget. 2016;7:7161-78 pubmed publisher
  409. Pivonello C, Negri M, De Martino M, Napolitano M, De Angelis C, Provvisiero D, et al. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma. Oncotarget. 2016;7:9718-31 pubmed publisher
  410. Chhibber Goel J, Coleman Vaughan C, Agrawal V, Sawhney N, Hickey E, Powell J, et al. γ-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signaling. J Biol Chem. 2016;291:5971-85 pubmed publisher
  411. Lu F, Chen H, Kossenkov A, DeWispeleare K, Won K, Lieberman P. EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1. PLoS Pathog. 2016;12:e1005339 pubmed publisher
  412. Chen N, Uddin B, Voit R, Schiebel E. Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion. Proc Natl Acad Sci U S A. 2016;113:990-5 pubmed publisher
  413. Amato K, Wang S, Tan L, Hastings A, Song W, Lovly C, et al. EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer. Cancer Res. 2016;76:305-18 pubmed publisher
  414. Azoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, et al. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation. Mol Cancer. 2016;15:3 pubmed publisher
  415. Liberante F, Pouryahya T, McMullin M, Zhang S, Mills K. Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia. Oncotarget. 2016;7:6609-19 pubmed publisher
  416. Terranova Barberio M, Roca M, Zotti A, Leone A, Bruzzese F, Vitagliano C, et al. Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression. Oncotarget. 2016;7:7715-31 pubmed publisher
  417. Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich M, Lim R, et al. FOXO1 couples metabolic activity and growth state in the vascular endothelium. Nature. 2016;529:216-20 pubmed publisher
  418. Han M, Lee D, Woo S, Seo B, Min K, Kim S, et al. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells. Sci Rep. 2016;6:18642 pubmed publisher
  419. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed publisher
  420. Mir R, Bele A, Mirza S, Srivastava S, Olou A, Ammons S, et al. A Novel Interaction of Ecdysoneless (ECD) Protein with R2TP Complex Component RUVBL1 Is Required for the Functional Role of ECD in Cell Cycle Progression. Mol Cell Biol. 2015;36:886-99 pubmed publisher
  421. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed publisher
  422. Borriello A, Naviglio S, Bencivenga D, Caldarelli I, Tramontano A, Speranza M, et al. Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation. Oxid Med Cell Longev. 2016;2016:2481865 pubmed publisher
  423. Yuniati L, van der Meer L, Tijchon E, van Ingen Schenau D, van Emst L, Levers M, et al. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress. Oncotarget. 2016;7:3128-43 pubmed publisher
  424. Obermeier K, Sachsenweger J, Friedl T, Pospiech H, Winqvist R, Wiesmüller L. Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients. Oncogene. 2016;35:3796-806 pubmed publisher
  425. Trzeciecka A, Klossowski S, Bajor M, Zagozdzon R, Gaj P, Muchowicz A, et al. Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma. Oncotarget. 2016;7:1717-31 pubmed publisher
  426. Cataldo A, Cheung D, Balsari A, Tagliabue E, Coppola V, Iorio M, et al. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget. 2016;7:786-97 pubmed publisher
  427. Song H, Tao L, Chen C, Pan L, Hao J, Ni Y, et al. USP17-mediated deubiquitination and stabilization of HDAC2 in cigarette smoke extract-induced inflammation. Int J Clin Exp Pathol. 2015;8:10707-15 pubmed
  428. Ni Y, Tao L, Chen C, Song H, Li Z, Gao Y, et al. The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33. Int J Mol Sci. 2015;16:27956-66 pubmed publisher
  429. Chen J, Chen Y, Yen C, Chen W, Huang W. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. Oncotarget. 2016;7:473-89 pubmed publisher
  430. Cristini A, Park J, Capranico G, Legube G, Favre G, Sordet O. DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions. Nucleic Acids Res. 2016;44:1161-78 pubmed publisher
  431. El Khattouti A, Selimovic D, Hannig M, Taylor E, Abd Elmageed Z, Hassan S, et al. Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition. J Cell Mol Med. 2016;20:266-86 pubmed publisher
  432. Nakajima W, Sharma K, Hicks M, Le N, Brown R, Krystal G, et al. Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer. Cancer Biol Ther. 2016;17:27-35 pubmed publisher
  433. Alsafadi S, Tourpin S, Bessoltane N, Salomé Desnoulez S, Vassal G, André F, et al. Nuclear localization of the caspase-3-cleaved form of p73 in anoikis. Oncotarget. 2016;7:12331-43 pubmed publisher
  434. Momcilovic M, McMickle R, Abt E, Seki A, Simko S, Magyar C, et al. Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers. Cancer Res. 2015;75:4910-22 pubmed publisher
  435. Maxfield K, Taus P, Corcoran K, Wooten J, Macion J, Zhou Y, et al. Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer. Nat Commun. 2015;6:8840 pubmed publisher
  436. Phillips D, Xiao Y, Lam L, Litvinovich E, Roberts Rapp L, Souers A, et al. Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199). Blood Cancer J. 2015;5:e368 pubmed publisher
  437. Holmberg Olausson K, Elsir T, Moazemi Goudarzi K, Nistér M, Lindström M. NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape. Sci Rep. 2015;5:16495 pubmed publisher
  438. Draganov D, Gopalakrishna Pillai S, Chen Y, Zuckerman N, Moeller S, Wang C, et al. Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Sci Rep. 2015;5:16222 pubmed publisher
  439. Alayev A, Salamon R, Berger S, Schwartz N, Cuesta R, Snyder R, et al. mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation. Oncogene. 2016;35:3535-43 pubmed publisher
  440. Ko T, Chin H, Chuah C, Huang J, Ng K, Khaw S, et al. The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia. Oncotarget. 2016;7:2721-33 pubmed publisher
  441. Hwang K, Choi Y. Modulation of Mitochondrial Antiviral Signaling by Human Herpesvirus 8 Interferon Regulatory Factor 1. J Virol. 2016;90:506-20 pubmed publisher
  442. Hassan M, El Khattouti A, Ejaeidi A, Ma T, Day W, Espinoza I, et al. Elevated Expression of Hepatoma Up-Regulated Protein Inhibits γ-Irradiation-Induced Apoptosis of Prostate Cancer Cells. J Cell Biochem. 2016;117:1308-18 pubmed publisher
  443. Xu S, Huang J, Chen M, Zeng M, Zou F, Chen D, et al. Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation. Oncotarget. 2017;8:12705-12716 pubmed publisher
  444. Li K, Gao B, Li J, Chen H, Li Y, Wei Y, et al. ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription. Oncotarget. 2015;6:38107-26 pubmed publisher
  445. Gao L, Tang H, He H, Liu J, Mao J, Ji H, et al. Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats. Front Pharmacol. 2015;6:215 pubmed publisher
  446. Campo Verde Arboccó F, Sasso C, Actis E, Carón R, Hapon M, Jahn G. Hypothyroidism advances mammary involution in lactating rats through inhibition of PRL signaling and induction of LIF/STAT3 mRNAs. Mol Cell Endocrinol. 2016;419:18-28 pubmed publisher
  447. Mazzacurati L, Lambert Q, Pradhan A, Griner L, Huszar D, Reuther G. The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells. Oncotarget. 2015;6:40141-57 pubmed publisher
  448. Sabirzhanov B, Stoica B, Zhao Z, Loane D, Wu J, Dorsey S, et al. miR-711 upregulation induces neuronal cell death after traumatic brain injury. Cell Death Differ. 2016;23:654-68 pubmed publisher
  449. Montes M, Coiras M, Becerra S, Moreno Castro C, Mateos E, Majuelos J, et al. Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing. PLoS ONE. 2015;10:e0139812 pubmed publisher
  450. Young L, Marzio A, Pérez Durán P, Reid D, Meredith D, Roberti D, et al. TIMELESS Forms a Complex with PARP1 Distinct from Its Complex with TIPIN and Plays a Role in the DNA Damage Response. Cell Rep. 2015;13:451-459 pubmed publisher
  451. van Geldermalsen M, Wang Q, Nagarajah R, Marshall A, Thoeng A, Gao D, et al. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene. 2016;35:3201-8 pubmed publisher
  452. Hwang J, Sung W, Tu H, Hsieh K, Yeh C, Chen C, et al. The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma. PLoS ONE. 2015;10:e0139435 pubmed publisher
  453. Ambroise G, Portier A, Roders N, Arnoult D, Vazquez A. Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells. Oncotarget. 2015;6:38181-94 pubmed publisher
  454. Voets E, Marsman J, Demmers J, Beijersbergen R, Wolthuis R. The lethal response to Cdk1 inhibition depends on sister chromatid alignment errors generated by KIF4 and isoform 1 of PRC1. Sci Rep. 2015;5:14798 pubmed publisher
  455. Hu D, Gur M, Zhou Z, Gamper A, Hung M, Fujita N, et al. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. Nat Commun. 2015;6:8419 pubmed publisher
  456. Pelish H, Liau B, Nitulescu I, Tangpeerachaikul A, Poss Z, Da Silva D, et al. Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature. 2015;526:273-276 pubmed publisher
  457. Mazur P, Herner A, Mello S, Wirth M, Hausmann S, Sánchez Rivera F, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med. 2015;21:1163-71 pubmed publisher
  458. Hilton B, Li Z, Musich P, Wang H, Cartwright B, SERRANO M, et al. ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1. Mol Cell. 2015;60:35-46 pubmed publisher
  459. Skrzypek K, Kusienicka A, Szewczyk B, Adamus T, Lukasiewicz E, Miekus K, et al. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression. Oncotarget. 2015;6:31378-98 pubmed publisher
  460. Anderson K, Russell A, Foletta V. NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity. FEBS Open Bio. 2015;5:668-81 pubmed publisher
  461. Charni M, Molchadsky A, Goldstein I, Solomon H, Tal P, Goldfinger N, et al. Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation. Cell Death Differ. 2016;23:509-20 pubmed publisher
  462. Machado Neto J, de Melo Campos P, Favaro P, Lazarini M, da Silva Santos Duarte A, Lorand Metze I, et al. Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells. Oncotarget. 2015;6:29573-84 pubmed publisher
  463. Bailey M, Singh T, Mero P, Moffat J, Hieter P. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint. Genetics. 2015;201:885-95 pubmed publisher
  464. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  465. Weaver A, Cooper T, Rodriguez M, Trummell H, Bonner J, Rosenthal E, et al. DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma. Oncotarget. 2015;6:26995-7007 pubmed publisher
  466. Xia H, Najafov A, Geng J, Galan Acosta L, Han X, Guo Y, et al. Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death. J Cell Biol. 2015;210:705-16 pubmed publisher
  467. Inaguma S, Ito H, Riku M, Ikeda H, Kasai K. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. Oncotarget. 2015;6:28257-68 pubmed publisher
  468. Tiffen J, Gunatilake D, Gallagher S, Gowrishankar K, Heinemann A, Cullinane C, et al. Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes. Oncotarget. 2015;6:27023-36 pubmed publisher
  469. Li X, Liang Q, Liu W, Zhang N, Xu L, Zhang X, et al. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway. Oncogene. 2016;35:2453-64 pubmed publisher
  470. Fan L, Peng G, Sahgal N, Fazli L, Gleave M, Zhang Y, et al. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival. Oncogene. 2016;35:2441-52 pubmed publisher
  471. Sakabe I, Hu R, Jin L, Clarke R, Kasid U. TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling. Breast Cancer Res Treat. 2015;153:285-97 pubmed publisher
  472. Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 2015;15:577 pubmed publisher
  473. Hermanova I, Arruabarrena Aristorena A, Valis K, Nůsková H, Alberich Jorda M, Fiser K, et al. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells. Leukemia. 2016;30:209-18 pubmed publisher
  474. Zhang X, Wang X, Wu T, Li B, Liu T, Wang R, et al. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci Rep. 2015;5:12579 pubmed publisher
  475. Dahlhoff M, Schäfer M, Muzumdar S, Rose C, Schneider M. ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis. Mol Oncol. 2015;9:1825-33 pubmed publisher
  476. Zhang L, Dai F, Sheng P, Chen Z, Xu Q, Guo Y. Resveratrol analogue 3,4,4'-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro. Acta Pharmacol Sin. 2015;36:1256-65 pubmed publisher
  477. Geletu M, Guy S, Greer S, Raptis L. Differential effects of polyoma virus middle tumor antigen mutants upon gap junctional, intercellular communication. Exp Cell Res. 2015;336:223-31 pubmed publisher
  478. Sarojini S, Pecora A, Milinovikj N, Barbiere J, Gupta S, Hussain Z, et al. A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma Res. 2015;25:376-89 pubmed publisher
  479. Berens C, Bisle S, Klingenbeck L, Lührmann A. Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling. J Vis Exp. 2015;:e52903 pubmed publisher
  480. Patergnani S, Giorgi C, Maniero S, Missiroli S, Maniscalco P, Bononi I, et al. The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition. Oncotarget. 2015;6:23427-44 pubmed
  481. Hamacher Brady A, Brady N. Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation. J Biol Chem. 2015;290:22005-18 pubmed publisher
  482. Sun Q, Jin C, Zhu L, Liang M, Li C, Cardona C, et al. Host Responses and Regulation by NFκB Signaling in the Liver and Liver Epithelial Cells Infected with A Novel Tick-borne Bunyavirus. Sci Rep. 2015;5:11816 pubmed publisher
  483. Breslin C, Hornyak P, Ridley A, Rulten S, Hanzlikova H, Oliver A, et al. The XRCC1 phosphate-binding pocket binds poly (ADP-ribose) and is required for XRCC1 function. Nucleic Acids Res. 2015;43:6934-44 pubmed publisher
  484. Ciamporcero E, Shen H, Ramakrishnan S, Yu Ku S, Chintala S, Shen L, et al. YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage. Oncogene. 2016;35:1541-53 pubmed publisher
  485. Liu K, Chuang S, Long C, Lee Y, Wang C, Lu M, et al. Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. Am J Physiol Renal Physiol. 2015;309:F318-31 pubmed publisher
  486. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  487. Dettmer U, Newman A, Soldner F, Luth E, Kim N, von Saucken V, et al. Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015;6:7314 pubmed publisher
  488. Petroni M, Sardina F, Heil C, Sahún Roncero M, Colicchia V, Veschi V, et al. The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress. Cell Death Differ. 2016;23:197-206 pubmed publisher
  489. Bock F, Tanzer M, Haschka M, Krumschnabel G, Sohm B, Goetsch K, et al. The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death. Sci Rep. 2015;5:11268 pubmed publisher
  490. Amente S, Milazzo G, Sorrentino M, Ambrosio S, Di Palo G, Lania L, et al. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma. Oncotarget. 2015;6:14572-83 pubmed
  491. Min H, Yun H, Lee J, Lee H, Cho J, Jang H, et al. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Mol Cancer. 2015;14:113 pubmed publisher
  492. Krossa S, Schmitt A, Hattermann K, Fritsch J, Scheidig A, Mehdorn H, et al. Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1. Oncotarget. 2015;6:21029-45 pubmed
  493. Izhar L, Adamson B, Ciccia A, Lewis J, Pontano Vaites L, Leng Y, et al. A Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factors. Cell Rep. 2015;11:1486-500 pubmed publisher
  494. Yang K, Kohler R, Landon M, Giedt R, Weissleder R. Single cell resolution in vivo imaging of DNA damage following PARP inhibition. Sci Rep. 2015;5:10129 pubmed publisher
  495. Hao W, Yuan X, Yu L, Gao C, Sun X, Wang D, et al. Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways. Sci Rep. 2015;5:10336 pubmed publisher
  496. Adhikary G, Grun D, Balasubramanian S, Kerr C, Huang J, Eckert R. Survival of skin cancer stem cells requires the Ezh2 polycomb group protein. Carcinogenesis. 2015;36:800-10 pubmed publisher
  497. Kumar S, Ingle H, Mishra S, Mahla R, Kumar A, Kawai T, et al. IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity. Cell Death Dis. 2015;6:e1758 pubmed publisher
  498. Cheng H, Liang Y, Kuo Y, Chuu C, Lin C, Lee M, et al. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015;6:e1753 pubmed publisher
  499. Huang C, Chao C, Lee Y, Lu M, Cheng J, Yang Y, et al. Paraquat Induces Cell Death Through Impairing Mitochondrial Membrane Permeability. Mol Neurobiol. 2016;53:2169-88 pubmed publisher
  500. Qiu J, Zhang Y, Li Y, Zhao J, Zhang W, Jiang Q, et al. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter. Oncotarget. 2015;6:15494-509 pubmed
  501. Luo T, Fu J, Xu A, Su B, Ren Y, Li N, et al. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression. Autophagy. 2016;12:1355-71 pubmed publisher
  502. Zhang P, Yang X, Ma X, Ingram D, Lazar A, Torres K, et al. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway. Mol Cancer. 2015;14:55 pubmed publisher
  503. Yang L, Zhang S, George S, Teng R, You X, Xu M, et al. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms. Oncotarget. 2015;6:14953-69 pubmed
  504. Ferreira R, Law M, Jahn S, Davis B, Heldermon C, Reinhard M, et al. Novel agents that downregulate EGFR, HER2, and HER3 in parallel. Oncotarget. 2015;6:10445-59 pubmed
  505. Wang W, Huang X, Xin H, Fu M, Xue A, Wu Z. TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase. J Biol Chem. 2015;290:13372-85 pubmed publisher
  506. Zhang D, Zhu L, Li C, Mu J, Fu Y, Zhu Q, et al. Sialyltransferase7A, a Klf4-responsive gene, promotes cardiomyocyte apoptosis during myocardial infarction. Basic Res Cardiol. 2015;110:28 pubmed publisher
  507. Kim D, Fiske B, Birsoy K, Freinkman E, Kami K, Possemato R, et al. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature. 2015;520:363-7 pubmed publisher
  508. Neira Peña T, Rojas Mancilla E, Munoz Vio V, Perez R, Gutierrez Hernandez M, Bustamante D, et al. Perinatal asphyxia leads to PARP-1 overactivity, p65 translocation, IL-1β and TNF-α overexpression, and apoptotic-like cell death in mesencephalon of neonatal rats: prevention by systemic neonatal nicotinamide administration. Neurotox Res. 2015;27:453-65 pubmed publisher
  509. Popp M, Maquat L. Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics. Nat Commun. 2015;6:6632 pubmed publisher
  510. Salvucci O, Ohnuki H, Maric D, Hou X, Li X, Yoon S, et al. EphrinB2 controls vessel pruning through STAT1-JNK3 signalling. Nat Commun. 2015;6:6576 pubmed publisher
  511. Sonnemann J, Grauel D, Blümel L, Hentschel J, Marx C, Blumrich A, et al. RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status. Eur J Cancer. 2015;51:841-51 pubmed publisher
  512. Leclere L, Fransolet M, Côté F, Cambier P, Arnould T, Van Cutsem P, et al. Heat-modified citrus pectin induces apoptosis-like cell death and autophagy in HepG2 and A549 cancer cells. PLoS ONE. 2015;10:e0115831 pubmed publisher
  513. Ma W, Na M, Tang C, Wang H, Lin Z. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. Mol Med Rep. 2015;12:1050-8 pubmed publisher
  514. Wang Y, Han A, Chen E, Singh R, Chichester C, Moore R, et al. The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells. Int J Oncol. 2015;46:1924-34 pubmed publisher
  515. Zub K, Sousa M, Sarno A, Sharma A, Demirovic A, Rao S, et al. Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells. PLoS ONE. 2015;10:e0119857 pubmed publisher
  516. Hodgson A, Wier E, Fu K, Sun X, Yu H, Zheng W, et al. Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction. PLoS Pathog. 2015;11:e1004705 pubmed publisher
  517. Wu Z, Wang C, Bai M, Li X, Mei Q, Li X, et al. An LRP16-containing preassembly complex contributes to NF-κB activation induced by DNA double-strand breaks. Nucleic Acids Res. 2015;43:3167-79 pubmed publisher
  518. Grabner B, Schramek D, Mueller K, Moll H, Svinka J, Hoffmann T, et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat Commun. 2015;6:6285 pubmed publisher
  519. Xie Q, Wu Q, Horbinski C, Flavahan W, Yang K, Zhou W, et al. Mitochondrial control by DRP1 in brain tumor initiating cells. Nat Neurosci. 2015;18:501-10 pubmed publisher
  520. Morlé A, Garrido C, Micheau O. Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion. Cell Death Dis. 2015;6:e1633 pubmed publisher
  521. Jeong H, Gil N, Lee H, Cho S, Kim K, Chun K, et al. Timely Degradation of Wip1 Phosphatase by APC/C Activator Protein Cdh1 is Necessary for Normal Mitotic Progression. J Cell Biochem. 2015;116:1602-12 pubmed publisher
  522. Suganya R, Chakraborty A, Miriyala S, Hazra T, Izumi T. Suppression of oxidative phosphorylation in mouse embryonic fibroblast cells deficient in apurinic/apyrimidinic endonuclease. DNA Repair (Amst). 2015;27:40-8 pubmed publisher
  523. Lu K, Fang X, Feng L, Jiang Y, Zhou X, Liu X, et al. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Cancer Lett. 2015;359:250-8 pubmed publisher
  524. Guarnerio J, Riccardi L, Taulli R, Maeda T, Wang G, Hobbs R, et al. A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells. Cancer Discov. 2015;5:396-409 pubmed publisher
  525. Wang S, Chen X, Hu J, Jiang J, Li Y, Chan Salis K, et al. ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells. Mol Cancer Ther. 2015;14:877-88 pubmed publisher
  526. Tao Y, Xu L, Lu J, Hu S, Fang F, Cao L, et al. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia. J Exp Clin Cancer Res. 2015;34:4 pubmed publisher
  527. Li G, Zhou J, Budhraja A, Hu X, Chen Y, Cheng Q, et al. Mitochondrial translocation and interaction of cofilin and Drp1 are required for erucin-induced mitochondrial fission and apoptosis. Oncotarget. 2015;6:1834-49 pubmed
  528. Jackson T, Du L, Janesko Feldman K, Vagni V, Dezfulian C, Poloyac S, et al. The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2015;35:655-66 pubmed publisher
  529. Majuelos Melguizo J, Rodríguez M, López Jiménez L, Rodríguez Vargas J, Martí Martín Consuegra J, Serrano Sáenz S, et al. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma. Oncotarget. 2015;6:4790-803 pubmed
  530. Xia J, Chen S, Lv Y, Lu L, Hu W, Zhou Y. ZGDHu-1 induces Gâ‚‚/M phase arrest and apoptosis in Kasumi-1 cells. Mol Med Rep. 2015;11:3398-404 pubmed publisher
  531. Newman E, Lu F, Bashllari D, Wang L, Opipari A, Castle V. Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma. Mol Cancer Res. 2015;13:470-82 pubmed publisher
  532. Mudie S, Bandarra D, Batie M, Biddlestone J, Moniz S, Ortmann B, et al. PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia. Cell Cycle. 2014;13:3878-91 pubmed publisher
  533. Mir S, George N, Zahoor L, Harms R, Guinn Z, SARVETNICK N. Inhibition of autophagic turnover in β-cells by fatty acids and glucose leads to apoptotic cell death. J Biol Chem. 2015;290:6071-85 pubmed publisher
  534. Zanotto Filho A, Braganhol E, Klafke K, Figueiró F, Terra S, Paludo F, et al. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. Cancer Lett. 2015;358:220-31 pubmed publisher
  535. Papanikolaou V, Stefanou N, Dubos S, Papathanasiou I, Palianopoulou M, Valiakou V, et al. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes. Cell Oncol (Dordr). 2015;38:155-64 pubmed publisher
  536. Zhang X, Cheng S, Bian K, Wang L, Zhang X, Yan B, et al. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin. Oncotarget. 2015;6:2277-89 pubmed
  537. Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson S, et al. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. Oncogene. 2015;34:4879-89 pubmed publisher
  538. Green A, Caracappa D, Benhasouna A, Alshareeda A, Nolan C, Macmillan R, et al. Biological and clinical significance of PARP1 protein expression in breast cancer. Breast Cancer Res Treat. 2015;149:353-62 pubmed publisher
  539. Wang S, Park S, Kodali V, Han J, Yip T, Chen Z, et al. Identification of protein disulfide isomerase 1 as a key isomerase for disulfide bond formation in apolipoprotein B100. Mol Biol Cell. 2015;26:594-604 pubmed publisher
  540. Hennig D, Müller S, Wichmann C, Drube S, Pietschmann K, Pelzl L, et al. Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells. Br J Cancer. 2015;112:329-37 pubmed publisher
  541. Girotti M, Lopes F, Preece N, Niculescu Duvaz D, Zambon A, Davies L, et al. Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma. Cancer Cell. 2015;27:85-96 pubmed publisher
  542. Chen Y, Wei M, Wang C, Lee H, Pan S, Gao M, et al. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer. Cancer Lett. 2015;357:582-90 pubmed publisher
  543. Ma H, Yue X, Gao L, Liang X, Yan W, Zhang Z, et al. ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA. Oncotarget. 2015;6:1049-63 pubmed
  544. Rutz S, Kayagaki N, Phung Q, Eidenschenk C, Noubade R, Wang X, et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature. 2015;518:417-21 pubmed publisher
  545. Riggi N, Knoechel B, Gillespie S, Rheinbay E, Boulay G, Suvà M, et al. EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. Cancer Cell. 2014;26:668-681 pubmed publisher
  546. Ohoka N, Nagai K, Hattori T, Okuhira K, Shibata N, Cho N, et al. Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway. Cell Death Dis. 2014;5:e1513 pubmed publisher
  547. Qin J, Rajaratnam R, Feng L, Salami J, Barber Rotenberg J, Domsic J, et al. Development of organometallic S6K1 inhibitors. J Med Chem. 2015;58:305-14 pubmed publisher
  548. Gao S, Andreeva K, Cooper N. Ischemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway. Mol Vis. 2014;20:1374-87 pubmed
  549. Alayev A, Berger S, Kramer M, Schwartz N, Holz M. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells. J Cell Biochem. 2015;116:450-7 pubmed publisher
  550. Holland W, Chinn D, Lara P, Gandara D, Mack P. Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines. J Cancer Res Clin Oncol. 2015;141:615-26 pubmed publisher
  551. Van Deun J, Mestdagh P, Sormunen R, Cocquyt V, Vermaelen K, Vandesompele J, et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles. 2014;3: pubmed publisher
  552. Wang Y, Kuramitsu Y, Tokuda K, Baron B, Kitagawa T, Akada J, et al. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. PLoS ONE. 2014;9:e109076 pubmed publisher
  553. Steffensen M, Fenger C, Christensen J, Jørgensen C, Bassi M, Christensen J, et al. Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways. J Virol. 2014;88:14090-104 pubmed publisher
  554. Geserick P, Wang J, Feoktistova M, Leverkus M. The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin. Cell Death Dis. 2014;5:e1412 pubmed publisher
  555. Krukenberg K, Jiang R, Steen J, Mitchison T. Basal activity of a PARP1-NuA4 complex varies dramatically across cancer cell lines. Cell Rep. 2014;8:1808-1818 pubmed publisher
  556. Tao L, Chen C, Song H, Piccioni M, Shi G, Li B. Deubiquitination and stabilization of IL-33 by USP21. Int J Clin Exp Pathol. 2014;7:4930-7 pubmed
  557. Yang C, Chung A, Ku C, Brill L, Williams R, Wolf D. Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation. F1000Res. 2014;3:115 pubmed publisher
  558. Kolosenko I, Fryknäs M, Forsberg S, Johnsson P, Cheon H, Holvey Bates E, et al. Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs. Int J Cancer. 2015;136:E51-61 pubmed publisher
  559. Yang C, Matsuura K, Huang N, Robeson A, Huang B, Zhang L, et al. Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death. Oncogene. 2015;34:3264-72 pubmed publisher
  560. Casella C, Miller D, Lynch K, Brodsky A. Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells. Gynecol Oncol. 2014;135:333-41 pubmed publisher
  561. Kemp M, Gaddameedhi S, Choi J, Hu J, Sancar A. DNA repair synthesis and ligation affect the processing of excised oligonucleotides generated by human nucleotide excision repair. J Biol Chem. 2014;289:26574-83 pubmed publisher
  562. Allen K, Gourov A, HARTE C, Gao P, Lee C, Sylvain D, et al. Nucleolar integrity is required for the maintenance of long-term synaptic plasticity. PLoS ONE. 2014;9:e104364 pubmed publisher
  563. Senturk S, Yao Z, Camiolo M, Stiles B, Rathod T, Walsh A, et al. p53? is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state. Proc Natl Acad Sci U S A. 2014;111:E3287-96 pubmed publisher
  564. Smith C, Matheson T, Trombly D, Sun X, Campeau E, Han X, et al. A separable domain of the p150 subunit of human chromatin assembly factor-1 promotes protein and chromosome associations with nucleoli. Mol Biol Cell. 2014;25:2866-81 pubmed publisher
  565. Resch U, Cuapio A, Sturtzel C, Hofer E, de Martin R, Holper Schichl Y. Polyubiquitinated tristetraprolin protects from TNF-induced, caspase-mediated apoptosis. J Biol Chem. 2014;289:25088-100 pubmed publisher
  566. Roper S, Chrysanthou S, Senner C, Sienerth A, Gnan S, Murray A, et al. ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells. Nucleic Acids Res. 2014;42:8914-27 pubmed publisher
  567. George S, Vishwamitra D, Manshouri R, Shi P, Amin H. The ALK inhibitor ASP3026 eradicates NPM-ALK? T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model. Oncotarget. 2014;5:5750-63 pubmed
  568. Chihara T, Kitabayashi A, Morimoto M, Takeuchi K, Masuyama K, Tonoki A, et al. Caspase inhibition in select olfactory neurons restores innate attraction behavior in aged Drosophila. PLoS Genet. 2014;10:e1004437 pubmed publisher
  569. Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, et al. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. J Pathol. 2014;234:302-15 pubmed publisher
  570. FitzGerald J, Murillo L, O Brien G, O Connell E, O Connor A, Wu K, et al. A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response. PLoS ONE. 2014;9:e98891 pubmed publisher
  571. Zeng L, Holly J, Perks C. Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells. Front Endocrinol (Lausanne). 2014;5:61 pubmed publisher
  572. Raimondi L, Amodio N, Di Martino M, Altomare E, Leotta M, Caracciolo D, et al. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity. Oncotarget. 2014;5:3039-54 pubmed
  573. Cazanave S, Wang X, Zhou H, Rahmani M, Grant S, Durrant D, et al. Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death Differ. 2014;21:1303-12 pubmed publisher
  574. Hegde V, Vogel R, Feany M. Glia are critical for the neuropathology of complex I deficiency in Drosophila. Hum Mol Genet. 2014;23:4686-92 pubmed publisher
  575. Wang X, Stafford W, Mazurkiewicz M, Fryknäs M, Brjnic S, Zhang X, et al. The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death. Mol Pharmacol. 2014;85:932-45 pubmed publisher
  576. Chou C, Huang N, Jhuang S, Pan H, Peng N, Cheng J, et al. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions. PLoS ONE. 2014;9:e93934 pubmed publisher
  577. Matsumoto T, Tabata K, Suzuki T. The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells. Biol Pharm Bull. 2014;37:633-41 pubmed
  578. Bhattacharyya S, Ghosh S, Sil P. Amelioration of aspirin induced oxidative impairment and apoptotic cell death by a novel antioxidant protein molecule isolated from the herb Phyllanthus niruri. PLoS ONE. 2014;9:e89026 pubmed publisher
  579. Brubaker S, Gauthier A, Mills E, Ingolia N, Kagan J. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell. 2014;156:800-11 pubmed publisher
  580. Nakajima W, Hicks M, Tanaka N, Krystal G, Harada H. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer. Cell Death Dis. 2014;5:e1052 pubmed publisher
  581. Pavet V, Shlyakhtina Y, He T, Ceschin D, Kohonen P, Perala M, et al. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells. Cell Death Dis. 2014;5:e1043 pubmed publisher
  582. Cheng Y, Holloway M, Nguyen K, McCauley D, Landesman Y, Kauffman M, et al. XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer. Mol Cancer Ther. 2014;13:675-86 pubmed publisher
  583. Colin Cassin C, Yao X, Cerella C, Chbicheb S, Kuntz S, Mazerbourg S, et al. PPAR?-inactive ?2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells. Mol Carcinog. 2015;54:393-404 pubmed publisher
  584. Rubio N, Verrax J, Dewaele M, Verfaillie T, Johansen T, Piette J, et al. p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling. Free Radic Biol Med. 2014;67:292-303 pubmed publisher
  585. Wang J, Chen J, Miller D, Li W. Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanoma. Mol Cancer Ther. 2014;13:16-26 pubmed publisher
  586. Gastaldello S, Chen X, Callegari S, Masucci M. Caspase-1 promotes Epstein-Barr virus replication by targeting the large tegument protein deneddylase to the nucleus of productively infected cells. PLoS Pathog. 2013;9:e1003664 pubmed publisher
  587. Shats I, Gatza M, Liu B, Angus S, You L, Nevins J. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function. Cancer Res. 2013;73:6056-67 pubmed publisher
  588. Tesoriere L, Attanzio A, Allegra M, Gentile C, Livrea M. Indicaxanthin inhibits NADPH oxidase (NOX)-1 activation and NF-?B-dependent release of inflammatory mediators and prevents the increase of epithelial permeability in IL-1?-exposed Caco-2 cells. Br J Nutr. 2014;111:415-23 pubmed publisher
  589. Snyder A, Dulin Smith A, Houston R, Durban A, Brisbin B, Oostra T, et al. Expression pattern of id proteins in medulloblastoma. Pathol Oncol Res. 2013;19:437-46 pubmed publisher
  590. Lonskaya I, Hebron M, Algarzae N, Desforges N, Moussa C. Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson's disease. Neuroscience. 2013;232:90-105 pubmed publisher
  591. Lin Y, Richards F, Krippendorff B, Bramhall J, Harrington J, Bapiro T, et al. Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells. Br J Cancer. 2012;107:1692-701 pubmed publisher
  592. Wu X, Ellmann S, Rubin E, Gil M, Jin K, Han L, et al. ADP ribosylation by PARP-1 suppresses HOXB7 transcriptional activity. PLoS ONE. 2012;7:e40644 pubmed publisher
  593. Krajewska M, You Z, Rong J, Kress C, Huang X, Yang J, et al. Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS ONE. 2011;6:e24341 pubmed publisher
  594. Sar P, Peter R, Rath B, Das Mohapatra A, Mishra S. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements. PLoS ONE. 2011;6:e20861 pubmed publisher
  595. Benatti P, Dolfini D, Vigano A, Ravo M, Weisz A, Imbriano C. Specific inhibition of NF-Y subunits triggers different cell proliferation defects. Nucleic Acids Res. 2011;39:5356-68 pubmed publisher
  596. Wan F, Weaver A, Gao X, Bern M, Hardwidge P, Lenardo M. IKK? phosphorylation regulates RPS3 nuclear translocation and NF-?B function during infection with Escherichia coli strain O157:H7. Nat Immunol. 2011;12:335-43 pubmed publisher
  597. Eisele G, Roth P, Hasenbach K, Aulwurm S, Wolpert F, Tabatabai G, et al. APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo. Neuro Oncol. 2011;13:155-64 pubmed publisher
  598. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer. 2011;128:1793-803 pubmed publisher
  599. Bombarde O, Boby C, Gomez D, Frit P, Giraud Panis M, Gilson E, et al. TRF2/RAP1 and DNA-PK mediate a double protection against joining at telomeric ends. EMBO J. 2010;29:1573-84 pubmed publisher
  600. Sémiramoth N, Gleizes A, Turbica I, Sandré C, Marin Esteban V, Gorges R, et al. Afa/Dr-expressing, diffusely adhering Escherichia coli strain C1845 triggers F1845 fimbria-dependent phosphatidylserine externalization on neutrophil-like differentiated PLB-985 cells through an apoptosis-independent mechanism. Infect Immun. 2010;78:2974-83 pubmed publisher
  601. Koschny R, Holland H, Sykora J, Erdal H, Krupp W, Bauer M, et al. Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis. J Neurooncol. 2010;97:171-85 pubmed publisher
  602. Rossi M, Carbone M, Mostocotto C, Mancone C, Tripodi M, Maione R, et al. Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J Biol Chem. 2009;284:31616-24 pubmed publisher
  603. Yung T, Narita T, Komori T, Yamaguchi Y, Handa H. Cellular dynamics of the negative transcription elongation factor NELF. Exp Cell Res. 2009;315:1693-705 pubmed publisher
  604. Koschny R, Ganten T, Sykora J, Haas T, Sprick M, Kolb A, et al. TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window. Hepatology. 2007;45:649-58 pubmed
  605. Martin Latil S, Mousson L, Autret A, Colbere Garapin F, Blondel B. Bax is activated during rotavirus-induced apoptosis through the mitochondrial pathway. J Virol. 2007;81:4457-64 pubmed
  606. Zhu C, Wang X, Huang Z, Qiu L, Xu F, Vahsen N, et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 2007;14:775-84 pubmed
  607. Duensing A, Medeiros F, McConarty B, Joseph N, Panigrahy D, Singer S, et al. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene. 2004;23:3999-4006 pubmed